Novel human proteins and polynucleotides encoding the same

ABSTRACT

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

[0001] The present application claims the benefit of U.S. Provisional Application No. 60/186,557 which was filed on Mar. 2, 2000 and is herein incorporated by reference in its entirety.

INTRODUCTION

[0002] The present invention relates to the discovery, identification, and characterization of novel human polynucleotides encoding proteins that share sequence similarity with mammalian GPI-anchored P137 protein, cerebellin and C1Q proteins. The invention encompasses the described polynucleotides, host cell expression systems, the encoded proteins, fusion proteins, polypeptides and peptides, antibodies to the encoded proteins and peptides, and genetically engineered animals that either lack or over express the disclosed polynucleotides, antagonists and agonists of the proteins, and other compounds that modulate the expression or activity of the proteins encoded by the disclosed polynucleotides that can be used for diagnosis, drug screening, clinical trial monitoring, and the treatment of diseases and disorders.

BACKGROUND OF THE INVENTION

[0003] Proteins provide structural, enzymatic, transport, and signaling functions in cells and tissues. As such, proteins can be used as therapeutics, drug targets, or as diagnostic factors.

SUMMARY OF THE INVENTION

[0004] The present invention relates to the discovery, identification, and characterization of nucleotides that encode novel human proteins, and the corresponding amino acid sequences of these proteins. The novel human proteins (NHPS) described for the first time herein share structural similarity with mammalian membrane proteins (tumor associated markers) and secreted proteins and peptides such as, but not limited to, cerebellin, C1Q, and collagens.

[0005] The novel human nucleic acid sequences described herein, encode alternative proteins/open reading frames (ORFs) of 162, 28, 278, 1.042, 908, 1,091, 957, 1,126, 992, 1,043, 909, 1,092, 958, 1,127, 993, 877, 743, 926, 792, 961, and 827 amino acids in length (SEQ ID NOS:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, and 42 respectively).

[0006] The invention also encompasses agonists and antagonists of the described NHPs, including small molecules, large molecules, mutant NHPs, or portions thereof, that compete with native NHP, peptides, and antibodies, as well as nucleotide sequences that can be used to inhibit the expression of the described NHPs (e.g., antisense and ribozyme molecules, and gene or regulatory sequence replacement constructs) or to enhance the expression of the described NHP polynucleotides (e.g., expression constructs that place the described polynucleotide under the control of a strong promoter system), and transgenic animals that express a NHP transgene, or “knock-outs” (which can be conditional) that do not express a functional NHP. Several knockout ES cell lines have been produced that contain gene trap mutations in a murine homolog of the described NHPs.

[0007] Further, the present invention also relates to processes for identifying compounds that modulate, i.e., act as agonists or antagonists, of NHP expression and/or NHP activity that utilize purified preparations of the described NHPs and/or NHP product, or cells expressing the same. Such compounds can be used as therapeutic agents for the treatment of any of a wide variety of symptoms associated with biological disorders or imbalances.

DESCRIPTION OF THE SEQUENCE LISTING AND FIGURES

[0008] The Sequence Listing provides the sequences of the described NHP ORFs that encode the described NHP amino acid sequences. SEQ ID NO:43 describes nucleotides encoding a NHP ORF along with regions of flanking sequence.

DETAILED DESCRIPTION OF THE INVENTION

[0009] The NHPs described for the first time herein are novel proteins that may be expressed in, inter alia, human cell lines, pituitary, cerebellum, spinal cord, thymus, spleen, lymph node, bone marrow, trachea, kidney, fetal liver, liver, prostate, testis, thyroid, salivary gland, stomach, small intestine, colon, skeletal muscle, uterus, placenta, mammary gland, adipose, esophagus, bladder, cervix, rectum, pericardium, hypothalamus, ovary, fetal kidney, fetal lung, and gene trapped human cells.

[0010] The present invention encompasses the nucleotides presented in the Sequence Listing, host cells expressing such nucleotides, the expression products of such nucleotides, and: (a) nucleotides that encode mammalian homologs of the described polynucleotides, including the specifically described NHPs, and the NHP products; (b) nucleotides that encode one or more portions of the NHPs that correspond to functional domains, and the polypeptide products specified by such nucleotide sequences, including but not limited to the novel regions of any active domain(s); (c) isolated nucleotides that encode mutant versions, engineered or naturally occurring, of the described NHPs in which all or a part of at least one domain is deleted or altered, and the,polypeptide products specified by such nucleotide sequences, including but not limited to soluble proteins and peptides in which all or a portion of the signal (or hydrophobic transmembrane) sequence is deleted; (d) nucleotides that encode chimeric fusion proteins containing all or a portion of a coding region of an NHP, or one of its domains (e.g., a receptor or ligand binding domain, accessory protein/self-association domain, etc.) fused to another peptide or polypeptide; or (e) therapeutic or diagnostic derivatives of the described polynucleotides such as oligonucleotides, antisense polynucleotides, ribozymes, dsRNA, or gene therapy constructs comprising a sequence first disclosed in the Sequence Listing.

[0011] As discussed above, the present invention includes: (a) the human DNA sequences presented in the Sequence Listing (and vectors comprising the same) and additionally contemplates any nucleotide sequence encoding a contiguous NHP open reading frame (ORF) that hybridizes to a complement of a DNA sequence presented in the Sequence Listing under highly stringent conditions, e.g., hybridization to filter-bound DNA in 0.5 M NaHPO₄, 7% sodium dodecyl sulfate (SDS), 1 mM EDTA at 65° C., and washing in 0.1xSSC/0.1% SDS at 68° C. (Ausubel F. M. et al., eds., 1989, Current Protocols in Molecular Biology, Vol. I, Green Publishing Associates, Inc., and John Wiley & sons, Inc., New York, at p. 2.10.3) and encodes a functionally equivalent gene product. Additionally contemplated are any nucleotide sequences that hybridize to the complement of a DNA sequence that encodes and expresses an amino acid sequence presented in the Sequence Listing under moderately stringent conditions, e.g., washing in 0.2xSSC/0.1% SDS at 42° C. (Ausubel et al., 1989, supra), yet still encodes a functionally equivalent NHP product. Functional equivalents of a NHP include naturally occurring NHPs present in other species and mutant NHPs whether naturally occurring or engineered (by site directed mutagenesis, gene shuffling, directed evolution as described in, for example, U.S. Pat. No. 5,837,458). The invention also includes degenerate nucleic acid variants of the disclosed NHP polynucleotide sequences.

[0012] Additionally contemplated are polynucleotides encoding NHP ORFs, or their functional equivalents, encoded by polynucleotide sequences that are about 99, 95, 90, or about 85 percent similar or identical to corresponding regions of the nucleotide sequences of the Sequence Listing (as measured by BLAST sequence comparison analysis using, for example, the GCG sequence analysis package using standard default settings).

[0013] The invention also includes nucleic acid molecules, preferably DNA molecules, that hybridize to, and are therefore the complements of, the described NHP nucleotide sequences. Such hybridization conditions may be highly stringent or less highly stringent, as described above. In instances where the nucleic acid molecules are deoxyoligonucleotides (“DNA oligos”), such molecules are generally about 16 to about 100 bases long, or about 20 to about 80, or about 34 to about 45 bases long, or any variation or combination of sizes represented therein that incorporate a contiguous region of sequence first disclosed in the Sequence Listing. Such oligonucleotides can be used in conjunction with the polymerase chain reaction (PCR) to screen libraries, isolate clones, and prepare cloning and sequencing templates, etc.

[0014] Alternatively, such NHP oligonucleotides can be used as hybridization probes for screening libraries, and assessing gene expression patterns (particularly using a micro array or high-throughput “chip” format). Additionally, a series of the described NHP oligonucleotide sequences, or the complements thereof, can be used to represent all or a portion of the described NHP sequences. An oligonucleotide or polynucleotide sequence first disclosed in at least a portion of one or more of the sequences of SEQ ID NOS: 1-43 can be used as a hybridization probe in conjunction with a solid support matrix/substrate (resins, beads, membranes, plastics, polymers, metal or metallized substrates, crystalline or polycrystalline substrates, etc.). Of particular note are spatially addressable arrays (i.e., gene chips, microtiter plates, etc.) of oligonucleotides and polynucleotides, or corresponding oligopeptides and polypeptides, wherein at least one of the biopolymers present on the spatially addressable array comprises an oligonucleotide or polynucleotide sequence first disclosed in at least one of the sequences of SEQ ID NOS: 1-43, or an amino acid sequence encoded thereby. Methods for attaching biopolymers to, or synthesizing biopolymers on, solid support matrices, and conducting binding studies thereon are disclosed in, inter alia, U.S. Pat. Nos. 5,700,637, 5,556,752, 5,744,305, 4,631,211, 5,445,934, 5,252,743, 4,713,326, 5,424,186, and 4,689,405 the disclosures of which are herein incorporated by reference in their entirety.

[0015] Addressable arrays comprising sequences first disclosed in SEQ ID NOS:1-43 can be used to identify and characterize the temporal and tissue specific expression of a gene. These addressable arrays incorporate oligonucleotide sequences of sufficient length to confer the required specificity, yet be within the limitations of the production technology. The length of these probes is within a range of between about 8 to about 2000 nucleotides. Preferably the probes consist of 60 nucleotides and more preferably 25 nucleotides from the sequences first disclosed in SEQ ID NOS:1-43.

[0016] For example, a series of the described oligonucleotide sequences, or the complements thereof, can be used in chip format to represent all or a portion of the described sequences. The oligonucleotides, typically between about 16 to about 40 (or any whole number within the stated range) nucleotides in length can partially overlap each other and/or the sequence may be represented using oligonucleotides that do not overlap. Accordingly, the described polynucleotide sequences shall typically comprise at least about two or three distinct oligonucleotide sequences of at least about 8 nucleotides in length that are each first disclosed in the described Sequence Listing. Such oligonucleotide sequences can begin at any nucleotide present within a sequence in the Sequence Listing and proceed in either a sense (5′-to-3′) orientation vis-a-vis the described sequence or in an antisense orientation.

[0017] Microarray-based analysis allows the discovery of broad patterns of genetic activity, providing new understanding of gene functions and generating novel and unexpected insight into transcriptional processes and biological mechanisms. The use of addressable arrays comprising sequences first disclosed in SEQ ID NOS:1-43 provides detailed information about transcriptional changes involved in a specific pathway, potentially leading to the identification of novel components or gene functions that manifest themselves as novel phenotypes.

[0018] Probes consisting of sequences first disclosed in SEQ ID NOS:1-43 can also be used in the identification, selection and validation of novel molecular targets for drug discovery. The use of these unique sequences permits the direct confirmation of drug targets and recognition of drug dependent changes in gene expression that are modulated through pathways distinct from the drugs intended target. These unique sequences therefore also have utility in defining and monitoring both drug action and toxicity. The described sequences can also be used to map that portion of the human genome that encodes and expresses the described sequences (i.e., for chromosome mapping).

[0019] As an example of utility, the sequences first disclosed in SEQ ID NOS:1-43 can be utilized in microarrays or other assay formats, to screen collections of genetic material from patients who have a particular medical condition. These investigations can also be carried out using the sequences first disclosed in SEQ ID NOS:1-43 in silico and by comparing previously collected genetic databases and the disclosed sequences using computer software known to those in the art.

[0020] Thus the sequences first disclosed in SEQ ID NOS:1-43 can be used to identify mutations associated with a particular disease and also as a diagnostic or prognostic assay.

[0021] Although the presently described sequences have been specifically described using nucleotide sequence, it should be appreciated that each of the sequences can uniquely be described using any of a wide variety of additional structural attributes, or combinations thereof. For example, a given sequence can be described by the net composition of the nucleotides present within a given region of the sequence in conjunction with the presence of one or more specific oligonucleotide sequence(s) first disclosed in the SEQ ID NOS: 1-43. Alternatively, a restriction map specifying the relative positions of restriction endonuclease digestion sites, or various palindromic or other specific oligonucleotide sequences can be used to structurally describe a given sequence. Such restriction maps, which are typically generated by widely available computer programs (e.g., the University of Wisconsin GCG sequence analysis package, SEQUENCHER 3.0, Gene Codes Corp., Ann Arbor, Mich., etc.), can optionally be used in conjunction with one or more discrete nucleotide sequence(s) present in the sequence that can be described by the relative position of the sequence relatve to one or more additional sequence(s) or one or more restriction sites present in the disclosed sequence.

[0022] For oligonucleotide probes, highly stringent conditions may refer, e.g., to washing in 6xSSC/0.05% sodium pyrophosphate at 37° C. (for 14-base oligos), 48° C. (for 17-base oligos), 55° C. (for 20-base oligos), and 60° C. (for 23-base oligos). These nucleic acid molecules may encode or act as NHP gene antisense molecules, useful, for example, in NHP gene regulation (for and/or as antisense primers in amplification reactions of NHP nucleic acid sequences). With respect to NHP gene regulation, such techniques can be used to regulate biological functions. Further, such sequences may be used as part of ribozyme and/or triple helix sequences that are also useful for NHP gene regulation.

[0023] Inhibitory antisense or double stranded oligonucleotides can additionally comprise at least one modified base moiety which is selected from the group including but not limited to 5-fluorouracil, 5-bromouracil, 5-chlorouracil, 5-iodouracil, hypoxanthine, xantine, 4-acetylcytosine, 5-(carboxyhydroxylmethyl) uracil, 5-carboxymethylaminomethyl-2-thiouridine, 5-carboxymethylaminomethyluracil, dihydrouracil, beta-D-galactosylqueosine, inosine, N6-isopentenyladenine, 1-methylguanine, 1-methylinosine, 2,2-dimethylguanine, 2-methyladenine, 2-methylguanine, 3-methylcytosine, 5-methylcytosine, N6-adenine, 7-methylguanine, 5-methylaminomethyluracil, 5-methoxyaminomethyl-2-thiouracil, beta-D-mannosylqueosine, 5′-methoxycarboxymethyluracil, 5-methoxyuracil, 2-methylthio-N6-isopentenyladenine, uracil-5-oxyacetic acid (v), wybutoxosine, pseudouracil, queosine, 2-thiocytosine, 5-methyl-2-thiouracil, 2-thiouracil, 4-thiouracil, 5-methyluracil, uracil-5-oxyacetic acid methylester, uracil-5-oxyacetic acid (v), 5-methyl-2-thiouracil, 3-(3-amino-3-N-2-carboxypropyl) uracil, (acp3)w, and 2,6-diaminopurine.

[0024] The antisense oligonucleotide can also comprise at least one modified sugar moiety selected from the group including but not limited to arabinose, 2-fluoroarabinose, xylulose, and hexose.

[0025] In yet another embodiment, the antisense oligonucleotide will comprise at least one modified phosphate backbone selected from the group consisting of a phosphorothioate, a phosphorodithioate, a phosphoramidothioate, a phosphoramidate, a phosphordiamidate, a methylphosphonate, an alkyl phosphotriester, and a formacetal or analog thereof.

[0026] In yet another embodiment, the antisense oligonucleotide is an α-anomeric oligonucleotide. An α-anomeric oligonucleotide forms specific double-stranded hybrids with complementary RNA in which, contrary to the usual β-units, the strands run parallel to each other (Gautier et al., 1987, Nucl. Acids Res. 15:6625-6641). The oligonucleotide is a 2′-0-methylribonucleotide (Inoue et al., 1987, Nucl. Acids Res. 15:6131-6148), or a chimeric RNA-DNA analogue (Inoue et al., 1987, FEBS Lett. 215:327-330). Alternatively, double stranded RNA can be used to disrupt the expression and function of a targeted NHP.

[0027] Oligonucleotides of the invention can be synthesized by standard methods known in the art, e.g. by use of an automated DNA synthesizer (such as are commercially available from Biosearch, Applied Biosystems, etc.). As examples, phosphorothioate oligonucleotides can be synthesized by the method of Stein et al. (1988, Nucl. Acids Res. 16:3209), and methylphosphonate oligonucleotides can be prepared by use of controlled pore glass polymer supports (Sarin et al., 1988, Proc. Natl. Acad. Sci. U.S.A. 85:7448-7451), etc.

[0028] Low stringency conditions are well known to those of skill in the art, and will vary predictably depending on the specific organisms from which the library and the labeled sequences are derived. For guidance regarding such conditions see, for example, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual (and periodic updates thereof), Cold Springs Harbor Press, N.Y.; and Ausubel et al., 1989, Current Protocols in Molecular Biology, Green Publishing Associates and Wiley Interscience, N.Y.

[0029] Alternatively, suitably labeled NHP nucleotide probes can be used to screen a human genomic library using appropriately stringent conditions or by PCR. The identification and characterization of human genomic clones is helpful for identifying polymorphisms (including, but not limited to, nucleotide repeats, microsatellite alleles, single nucleotide polymorphisms, or coding single nucleotide polymorphisms), determining the genomic structure of a given locus/allele, and designing diagnostic tests. For example, sequences derived from regions adjacent to the intron/exon boundaries of the human gene can be used to design primers for use in amplification assays to detect mutations within the exons, introns, splice sites (e.g., splice acceptor and/or donor sites), etc., that can be used in diagnostics and pharmacogenomics.

[0030] Further, a NHP gene homolog can be isolated from nucleic acid from an organism of interest by performing PCR using two degenerate or “wobble”oligonucleotide primer pools designed on the basis of amino acid sequences within the NHP products disclosed herein. The template for the reaction may be total RNA, mRNA, and/or cDNA obtained by reverse transcription of mRNA prepared from human or non-human cell lines or tissue known or suspected to express an allele of a NHP gene.

[0031] The PCR product can be subcloned and sequenced to ensure that the amplified sequences represent the sequence of the desired NHP gene. The PCR fragment can then be used to isolate a full length cDNA clone by a variety of methods. For example, the amplified fragment can be labeled and used to screen a cDNA library, such as a bacteriophage cDNA library. Alternatively, the labeled fragment can be used to isolate genomic clones via the screening of a genomic library.

[0032] PCR technology can also be used to isolate full length cDNA sequences. For example, RNA can be isolated, following standard procedures, from an appropriate cellular or tissue source (i.e., one known, or suspected, to express a NHP gene). A reverse transcription (RT) reaction can be performed on the RNA using an oligonucleotide primer specific for the most 5′ end of the amplified fragment for the priming of first strand synthesis. The resulting RNA/DNA hybrid may then be “tailed” using a standard terminal transferase reaction, the hybrid may be digested with RNase H, and second strand synthesis may then be primed with a complementary primer. Thus, cDNA sequences upstream of the amplified fragment can be isolated. For a review of cloning strategies that can be used, see e.g., Sambrook et al., 1989, supra.

[0033] A CDNA encoding a mutant NHP gene can be isolated, for example, by using PCR. In this case, the first cDNA strand may be synthesized by hybridizing an oligo-dT oligonucleotide to mRNA isolated from tissue known or suspected to be expressed in an individual putatively carrying a mutant NHP allele, and by extending the new strand with reverse transcriptase. The second strand of the cDNA is then synthesized using an oligonucleotide that hybridizes specifically to the 5′ end of the normal gene. Using these two primers, the product is then amplified via PCR, optionally cloned into a suitable vector, and subjected to DNA sequence analysis through methods well known to those of skill in the art. By comparing the DNA sequence of the mutant NHP allele to that of a corresponding normal NHP allele, the mutation(s) responsible for the loss or alteration of function of the mutant NHP gene product can be ascertained.

[0034] Alternatively, a genomic library can be constructed using DNA obtained from an individual suspected of or known to carry a mutant NHP allele (e.g., a person manifesting a NHP-associated phenotype such as, for example, obesity, high blood pressure, connective tissue disorders, infertility, etc.), or a cDNA library can be constructed using RNA from a tissue known, or suspected, to express a mutant NHP allele. A normal NHP gene, or any suitable fragment thereof, can then be labeled and used as a probe to identify the corresponding mutant NHP allele in such libraries. Clones containing mutant, NHP gene sequences can then be purified and subjected to sequence analysis according to methods well known to those skilled in the art.

[0035] Additionally, an expression library can be constructed utilizing cDNA synthesized from, for example, RNA isolated from a tissue known, or suspected, to express a mutant NHP allele in an individual suspected of or known to carry such a mutant allele. In this manner, gene products made by the putatively mutant tissue can be expressed and screened using standard antibody screening techniques in conjunction with antibodies raised against a normal NHP product, as described below. (For screening techniques, see, for example, Harlow, E. and Lane, eds., 1988, “Antibodies: A Laboratory Manual”, Cold Spring Harbor Press, Cold Spring Harbor.) Additionally, screening can be accomplished by screening with labeled NHP fusion proteins, such as, for example, alkaline phosphatase-NHP or NHP-alkaline phosphatase fusion proteins. In cases where a NHP mutation results in an expressed gene product with altered function (e.g., as a result of a missense or a frameshift mutation), polyclonal antibodies to a NHP are likely to cross-react with a corresponding mutant NHP gene product. Library clones detected via their reaction with such labeled antibodies can be purified and subjected to sequence analysis according to methods well known in the art.

[0036] The invention also encompasses (a) DNA vectors that contain any of the foregoing NHP coding sequences and/or their complements (i.e., antisense); (b) DNA expression vectors that contain any of the foregoing NHP coding sequences operatively associated with a regulatory element that directs the expression of the coding sequences (for example, baculo virus as described in U.S. Pat. No. 5,869,336 herein incorporated by reference); (c) genetically engineered host cells that contain any of the foregoing NHP coding sequences operatively associated with a regulatory element that directs the expression of the coding sequences in the host cell; and (d) genetically engineered host cells that express an endogenous NHP gene under the control of an exogenously introduced regulatory element (i.e., gene activation). As used herein, regulatory elements include, but are not limited to, inducible and non-inducible promoters, enhancers, operators and other elements known to those skilled in the art that drive and regulate expression. Such regulatory elements include but are not limited to the cytomegalovirus (hCMV) immediate early gene, regulatable, viral elements (particularly retroviral LTR promoters), the early or late promoters of SV40 adenovirus, the lac system, the trp system, the TAC system, the TRC system, the major operator and promoter regions of phage lambda, the control regions of fd coat protein, the promoter for 3-phosphoglycerate kinase (PGK), the promoters of acid phosphatase, and the promoters of the yeast α-mating factors.

[0037] The present invention also encompasses antibodies and anti-idiotypic antibodies (including Fab fragments), antagonists and agonists of the NHP, as well as compounds or nucleotide constructs that inhibit expression of a NHP gene (transcription factor inhibitors, antisense and ribozyme molecules, or gene or regulatory sequence replacement constructs), or promote the expression of a NHP (e.g., expression constructs in which NHP coding sequences are operatively associated with expression control elements such as promoters, promoter/enhancers, etc.).

[0038] The NHPs or NHP peptides, NHP fusion proteins, NHP nucleotide sequences, antibodies, antagonists and agonists can be useful for the detection of mutant NHPs or inappropriately expressed NHPs for the diagnosis of disease. The NHP proteins or peptides, NHP fusion proteins, NHP nucleotide sequences, host cell expression systems, antibodies, antagonists, agonists and genetically engineered cells and animals can be used for screening for drugs (or high throughput screening of combinatorial libraries) effective in the treatment of the symptomatic or phenotypic manifestations of perturbing the normal function of NHP in the body. The use of engineered host cells and/or animals may offer an advantage in that such systems allow not only for the identification of compounds that bind to the endogenous receptor for an NHP, but can also identify compounds that trigger NHP-mediated activities or pathways.

[0039] Finally, the NHP products can be used as therapeutics. For example, soluble derivatives such as NHP peptides/domains corresponding to NHPs, NHP fusion protein products (especially NHP-Ig fusion proteins, i.e., fusions of a NHP, or a domain of a NHP, to an IgFc), NHP antibodies and anti-idiotypic antibodies (including Fab fragments), antagonists or agonists (including compounds that modulate or act on downstream targets in a NHP-mediated pathway) can be used to directly treat diseases or disorders. For instance, the administration of an effective amount of soluble NHP, or a NHP-IgFc fusion protein or an anti-idiotypic antibody (or its Fab) that mimics the NHP could activate or effectively antagonize the endogenous NHP receptor. Nucleotide constructs encoding such NHP products can be used to genetically engineer host cells to express such products in vivo; these genetically engineered cells function as “bioreactors” in the body delivering a continuous supply of a NHP, a NHP peptide, or a NHP fusion protein to the body. Nucleotide constructs encoding functional NHPs, mutant NHPs, as well as antisense and ribozyme molecules can also be used in “gene therapy” approaches for the modulation of NHP expression. Thus, the invention also encompasses pharmaceutical formulations and methods for treating biological disorders.

[0040] Various aspects of the invention are described in greater detail in the subsections below.

THE NHP SEQUENCES

[0041] The cDNA sequences and the corresponding deduced amino acid sequences of the described NHPs are presented in the Sequence Listing. The NHP nucleotides were obtained from clustered human gene trapped sequences and a bone marrow cDNA library (Edge Biosystems, Gaithersburg, Md.).

[0042] SEQ ID NOS:1-43 describe sequences that are similar to those related to eucaryotic GPI-anchored P137 proteins (which is thought to facilitate transport of materials across epithelial surfaces), tumor-associated proteins, and precursors of secreted proteins. A polymorphism indicating that the three bases corresponding to positions 2,215-2,217 of, for example, SEQ ID NO:7 can be deleted (with as corresponding deletion of ala 739 from the region of sequence corresponding to, for example, SEQ ID NO:8). This deletion also results in the removal of a Pst I site (CTGCAG) and thus the described deletion further defines a restriction site polymorphism.

NHPS AND NHP POLYPEPTIDES

[0043] NHPs, polypeptides, peptide fragments, mutated, truncated, or deleted forms of the NHPs, and/or NHP fusion proteins can be prepared for a variety of uses. These uses include, but are not limited to, the generation of antibodies, as reagents in diagnostic assays, the identification of other cellular gene products related to a NHP, as reagents in assays for screening for compounds that can be as pharmaceutical reagents useful in the therapeutic treatment of mental, biological, or medical disorders and diseases. Given the similarity information and expression data, the described NHPs can be targeted (by drugs, oligos, antibodies, etc,) in order to treat disease, or to therapeutically augment the efficacy of, for example, chemotherapeutic agents used in the treatment of diseases such as, but not limited to, cancer, inflammation, hormonal disorders.

[0044] The Sequence Listing discloses the amino acid sequences encoded by the described NHP ORFs. The NHPs typically display have initiator methionines in DNA sequence contexts consistent with a translation initiation site.

[0045] The NHP amino acid sequences of the invention include the amino acid sequence presented in the Sequence Listing as well as analogues and derivatives thereof. Further, corresponding NHP homologues from other species are encompassed by the invention. In fact, any NHP protein encoded by the NHP nucleotide sequences described above are within the scope of the invention, as are any novel polynucleotide sequences encoding all or any novel portion of an amino acid sequence presented in the Sequence Listing. The degenerate nature of the genetic code is well known, and, accordingly, each amino acid presented in the Sequence Listing, is generically representative of the well known nucleic acid “triplet” codon, or in many cases codons, that can encode the amino acid. As such, as contemplated herein, the amino acid sequences presented in the Sequence Listing, when taken together with the genetic code (see, for example, Table 4-1 at page 109 of “Molecular Cell Biology”, 1986, J. Darnell et al. eds., Scientific American Books, New York, N.Y, herein incorporated by reference) are generically representative of all the various permutations and combinations of nucleic acid sequences that can encode such amino acid sequences.

[0046] The invention also encompasses proteins that are functionally equivalent to the NHPs encoded by the presently described nucleotide sequences as judged by any of a number of criteria, including, but not limited to, the ability to bind and cleave a substrate of a NHP, or the ability to effect an identical or complementary downstream pathway, or a change in cellular metabolism (e.g., proteolytic activity, ion flux, tyrosine phosphorylation, etc.). Such functionally equivalent NHP proteins include, but are not limited to, additions or substitutions of amino acid residues within the amino acid sequence encoded by the NHP nucleotide sequences described above, but which result in a silent change, thus producing a functionally equivalent gene product. Amino acid substitutions may be made on the basis of similarity in polarity, charge, solubility, hydrophobicity, hydrophilicity, and/or the amphipathic nature of the residues involved. For example, nonpolar (hydrophobic) amino acids include alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan, and methionine; polar neutral amino acids include glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine; positively charged (basic) amino acids include arginine, lysine, and histidine; and negatively charged (acidic) amino acids include aspartic acid and glutamic acid.

[0047] A variety of host-expression vector systems can be used to express the NHP nucleotide sequences of the invention. Where, as in the present instance, the NHP peptide or polypeptide is thought to be membrane protein, the hydrophobic regions of the protein can be excised and the resulting soluble peptide or polypeptide can be recovered from the culture media. Such expression systems also encompass engineered host cells that express a NHP, or functional equivalent, in situ. Purification or enrichment of a NHP from such expression systems can be accomplished using appropriate detergents and lipid micelles and methods well known to those skilled in the art. However, such engineered host cells themselves may be used in situations where it is important not only to retain the structural and functional characteristics of the NHP, but to assess biological activity, e.g., in drug screening assays.

[0048] The expression systems that may be used for purposes of the invention include but are not limited to microorganisms such as bacteria (e.g., E. coli, B. subtilis) transformed with recombinant bacteriophage DNA, plasmid DNA or cosmid DNA expression vectors containing NHP nucleotide sequences; yeast (e.g., Saccharomyces, Pichia) transformed with recombinant yeast expression vectors containing NHP nucleotide sequences; insect cell systems infected with recombinant virus expression vectors (e.g., baculovirus) containing NHP sequences; plant cell systems infected with recombinant virus expression vectors (e.g., cauliflower mosaic virus, CaMV; tobacco mosaic virus, TMV) or transformed with recombinant plasmid expression vectors (e.g., Ti plasmid) containing NHP nucleotide sequences; or mammalian cell systems (e.g., COS, CHO, BHK, 293, 3T3) harboring recombinant expression constructs containing promoters derived from the genome of mammalian cells (e.g., metallothionein promoter) or from mammalian viruses (e.g., the adenovirus late promoter; the vaccinia virus 7.5K promoter).

[0049] In bacterial systems, a number of expression vectors may be advantageously selected depending upon the use intended for the NHP product being expressed. For example, when a large quantity of such a protein is to be produced for the generation of pharmaceutical compositions of or containing NHP, or for raising antibodies to a NHP, vectors that direct the expression of high levels of fusion protein products that are readily purified may be desirable. Such vectors include, but are not limited, to the E. coli expression vector pUR278 (Ruther et al., 1983, EMBO J. 2:1791), in which a NHP coding sequence may be ligated individually into the vector in frame with the lacZ coding region so that a fusion protein is produced; pIN vectors (Inouye & Inouye, 1985, Nucleic Acids Res. 13:3101-3109; Van Heeke & Schuster, 1989, J. Biol. Chem. 264:5503-5509); and the like. PGEX vectors (Pharmacia or American Type Culture Collection) can also be used to express foreign polypeptides as fusion proteins with glutathione S-transferase (GST). In general, such fusion proteins are soluble and can easily be purified from lysed cells by adsorption to glutathione-agarose beads followed by elution in the presence of free glutathione. The PGEX vectors are designed to include thrombin or factor Xa protease cleavage sites so that the cloned target gene product can be released from the GST moiety.

[0050] In an insect system, Autographa californica nuclear polyhidrosis virus (AcNPV) is used as a vector to express foreign polynucleotides. The virus grows in Spodoptera frugiperda cells. A NHP coding sequence may be cloned individually into non-essential regions (for example the polyhedrin gene) of the virus and placed under control of an AcNPV promoter (for example the polyhedrin promoter). Successful insertion of NHP coding sequence will result in inactivation of the polyhedrin gene and production of non-occluded recombinant virus (i.e., virus lacking the proteinaceous coat coded for by the polyhedrin gene). These recombinant viruses are then used to infect Spodoptera frugiperda cells in which the inserted polynucleotide is expressed (e.g., see Smith et al., 1983, J. Virol. 46:584; Smith, U.S. Pat. No. 4,215,051).

[0051] In mammalian host cells, a number of viral-based expression systems may be utilized. In cases where an adenovirus is used as an expression vector, the NHP nucleotide sequence of interest may be ligated to an adenovirus transcription/translation control complex, e.g., the late promoter and tripartite leader sequence.

[0052] This chimeric gene may then be inserted in the adenovirus genome by in vitro or in vivo recombination. Insertion in a non-essential region of the viral genome (e.g., region E1 or E3) will result in a recombinant virus that is viable and capable of expressing a NHP product in infected hosts (e.g., See Logan & Shenk, 1984, Proc. Natl. Acad. Sci. USA 81:3655-3659). Specific initiation signals may also be required for efficient translation of inserted NHP nucleotide sequences. These signals include the ATG initiation codon and adjacent sequences. In cases where an entire NHP gene or CDNA, including its own initiation codon and adjacent sequences, is inserted into the appropriate expression vector, no additional translational control signals may be needed. However, in cases where only a portion of a NHP coding sequence is inserted, exogenous translational control signals, including, perhaps, the ATG initiation codon, must be provided. Furthermore, the initiation codon must be in phase with the reading frame of the desired coding sequence to ensure translation of the entire insert. These exogenous translational control signals and initiation codons can be of a variety of origins, both natural and synthetic. The efficiency of expression may be enhanced by the inclusion of appropriate transcription enhancer elements, transcription terminators, etc. (See Bitter et al., 1987, Methods in Enzymol. 153:516-544).

[0053] In addition, a host cell strain may be chosen that modulates the expression of the inserted sequences, or modifies and processes the gene product in the specific fashion desired. Such modifications (e.g., glycosylation) and processing (e.g., cleavage) of protein products may be important for the function of the protein. Different host cells have characteristic and specific mechanisms for the post-translational processing and modification of proteins and gene products. Appropriate cell lines or host systems can be chosen to ensure the correct modification and processing of the foreign protein expressed. To this end, eukaryotic host cells which possess the cellular machinery for proper processing of the primary transcript, glycosylation, and phosphorylation of the gene product may be used. Such mammalian host cells include, but are not limited to, CHO, VERO, BHK, HeLa, COS, MDCK, 293, 3T3, WI38, and in particular, human cell lines.

[0054] For long-term, high-yield production of recombinant proteins, stable expression is preferred. For example, cell lines which stably express the NHP sequences described above can be engineered. Rather than using expression vectors which contain viral origins of replication, host cells can be transformed with DNA controlled by appropriate expression control elements (e.g., promoter, enhancer sequences, transcription terminators, polyadenylation sites, etc.), and a selectable marker. Following the introduction of the foreign DNA, engineered cells may be allowed to grow for 1-2 days in an enriched media, and then are switched to a selective media. The selectable marker in the recombinant plasmid confers resistance to the selection and allows cells to stably integrate the plasmid into their chromosomes and grow to form foci which in turn can be cloned and expanded into cell lines. This method may advantageously be used to engineer cell lines which express the NHP product. Such engineered cell lines may be particularly useful in screening and evaluation of compounds that affect the endogenous activity of the NHP product.

[0055] A number of selection systems may be used, including but not limited to the herpes simplex virus thymidine kinase (Wigler, et al., 1977, Cell 11:223), hypoxanthine-guanine phosphoribosyltransferase (Szybalska & Szybalski, 1962, Proc. Natl. Acad. Sci. USA 48:2026), and adenine phosphoribosyltransferase (Lowy, et al., 1980, Cell 22:817) genes can be employed in tk⁻, hgprt⁻ or aprt⁻ cells, respectively. Also, antimetabolite resistance can be used as the basis of selection for the following genes: dhfr, which confers resistance to methotrexate (Wigler, et al., 1980, Natl. Acad. Sci. USA 77:3567; O'Hare, et al., 1981, Proc. Natl. Acad. Sci. USA 78:1527); gpt, which confers resistance to mycophenolic acid (Mulligan & Berg, 1981, Proc. Natl. Acad. Sci. USA 78:2072); neo, which confers resistance to the aminoglycoside G-418 (Colberre-Garapin, et al., 1981, J. Mol. Biol. 150:1); and hygro, which confers resistance to hygromycin (Santerre, et al., 1984, Gene 30:147).

[0056] Alternatively, any fusion protein can be readily purified by utilizing an antibody specific for the fusion protein being expressed. For example, a system described by Janknecht et al. allows for the ready purification of non-denatured fusion proteins expressed in human cell lines (Janknecht, et al., 1991, Proc. Natl. Acad. Sci. USA 88:8972-8976). In this system, the gene of interest is subcloned into a vaccinia recombination plasmid such that the gene's open reading frame is translationally fused to an amino-terminal tag consisting of six histidine residues. Extracts from cells infected with recombinant vaccinia virus are loaded onto Ni²⁺ nitriloacetic acid-agarose columns and histidine-tagged proteins are selectively eluted with imidazole-containing buffers.

[0057] Also encompassed by the present invention are fusion proteins that direct the NHP to a target organ and/or facilitate transport across the membrane into the cytosol. Conjugation of NHPs to antibody molecules or their Fab fragments could be used to target cells bearing a particular epitope. Attaching the appropriate signal sequence to the NHP would also transport the NHP to the desired location within the cell. Alternatively targeting of NHP or its nucleic acid sequence might be achieved using liposome or lipid complex based delivery systems. Such technologies are described in Liposomes:A Practical Approach, New, RRC ed., Oxford University Press, New York and in U.S. Pat. Nos. 4,594,595, 5,459,127, 5,948,767 and 6,110,490 and their respective disclosures which are herein incorporated by reference in their entirety. Additionally embodied are novel protein constructs engineered in such a way that they facilitate transport of the NHP to the target site or desired organ. This goal may be achieved by coupling of the NHP to a cytokine or other ligand that provides targeting specificity, and/or to a protein transducing domain (see generally U.S. applications Ser. No. 60/111,701 and 60/056,713, both of which are herein incorporated by reference, for examples of such transducing sequences) to facilitate passage across cellular membranes if needed and can optionally be engineered to include nuclear localization sequences when desired.

ANTIBODIES TO NHP PRODUCTS

[0058] Antibodies that specifically recognize one or more epitopes of a NHP, or epitopes of conserved variants of a NHP, or peptide fragments of a NHP are also encompassed by the invention. Such antibodies include but are not limited to polyclonal antibodies, monoclonal antibodies (mAbs), humanized or chimeric antibodies, single chain antibodies, Fab fragments, F(ab')₂ fragments, fragments produced by a Fab expression library, anti-idiotypic (anti-Id) antibodies, and epitope-binding fragments of any of the above.

[0059] The antibodies of the invention may be used, for example, in the detection of NHP in a biological sample and may, therefore, be utilized as part of a diagnostic or prognostic technique whereby patients may be tested for abnormal amounts of NHP. Such antibodies may also be utilized in conjunction with, for example, compound screening schemes for the evaluation of the effect of test compounds on expression and/or activity of a NHP gene product. Additionally, such antibodies can be used in conjunction gene therapy to, for example, evaluate the normal and/or engineered NHP-expressing cells prior to their introduction into the patient. Such antibodies may additionally be used as a method for the inhibition of abnormal NHP activity. Thus, such antibodies may, therefore, be utilized as part of treatment methods.

[0060] For the production of antibodies, various host animals may be immunized by injection with a NHP, an NHP peptide (e.g., one corresponding to a functional domain of an NHP), truncated NHP polypeptides (NHP in which one or more domains have been deleted), functional equivalents of the NHP or mutated variant of the NHP. Such host animals may include but are not limited to pigs, rabbits, mice, goats, and rats, to name but a few. Various adjuvants may be used to increase the immunological response, depending on the host species, including but not limited to Freund's adjuvant (complete and incomplete), mineral salts such as aluminum hydroxide or aluminum phosphate, surface active substances such as lysolecithin, pluronic polyols, polyanions, peptides, oil emulsions, and potentially useful human adjuvants such as BCG (bacille Calmette-Guerin) and Corynebacterium parvum. Alternatively, the immune response could be enhanced by combination and or coupling with molecules such as keyhole limpet hemocyanin, tetanus toxoid, diptheria toxoid, ovalbumin, cholera toxin or fragments thereof. Polyclonal antibodies are heterogeneous populations of antibody molecules derived from the sera of the immunized animals.

[0061] Monoclonal antibodies, which are homogeneous populations of antibodies to a particular antigen, can be obtained by any technique which provides for the production of antibody molecules by continuous cell lines in culture. These include, but are not limited to, the hybridoma technique of Kohler and Milstein, (1975, Nature 256:495-497; and U.S. Pat. No. 4,376,110), the human B-cell cell hybridoma technique (Kosbor et al., 1983, Immunology Today 4:72; Cole et al., 1983, Proc. Natl. Acad. Sci. USA 80:2026-2030), and the EBV-hybridoma technique (Cole et al., 1985, Monoclonal Antibodies And Cancer Therapy, Alan R. Liss, Inc., pp. 77-96). Such antibodies may be of any immunoglobulin class including IgG, IgM, IgE, IgA, IgD and any subclass thereof. The hybridoma producing the mAb of this invention may be cultivated in vitro or in vivo. Production of high titers of mAbs in vivo makes this the presently preferred method of production.

[0062] In addition, techniques developed for the production of “chimeric antibodies” (Morrison et al., 1984, Proc. Natl. Acad. Sci., 81:6851-6855; Neuberger et al., 1984, Nature, 312:604-608; Takeda et al., 1985, Nature, 314:452-454) by splicing the genes from a mouse antibody molecule of appropriate antigen specificity together with genes from a human antibody molecule of appropriate biological activity can be used. A chimeric antibody is a molecule in which different portions are derived from different animal species, such as those having a variable region derived from a murine mAb and a human immunoglobulin constant region. Such technologies are described in U.S. Pat. Nos. 6,075,181 and 5,877,397 and their respective disclosures which are herein incorporated by reference in their entirety. Also encompassed by the present invention is the use of fully humanized monoclonal antibodies as described in US Pat. No. 6,150,584 and respective disclosures which are herein incorporated by reference in their entirety.

[0063] Alternatively, techniques described for the production of single chain antibodies (U.S. Pat. No. 4,946,778; Bird, 1988, Science 242:423-426; Huston et al., 1988, Proc. Natl. Acad. Sci. USA 85:5879-5883; and Ward et al., 1989, Nature 341:544-546) can be adapted to produce single chain antibodies against NHP gene products. Single chain antibodies are formed by linking the heavy and light chain fragments of the Fv region via an amino acid bridge, resulting in a single chain polypeptide.

[0064] Antibody fragments which recognize specific epitopes may be generated by known techniques. For example, such fragments include, but are not limited to: the F(ab')₂ fragments which can be produced by pepsin digestion of the antibody molecule and the Fab fragments which can be generated by reducing the disulfide bridges of the F(ab')₂ fragments. Alternatively, Fab expression libraries may be constructed (Huse et al., 1989, Science, 246:1275-1281) to allow rapid and easy identification of monoclonal Fab fragments with the desired specificity.

[0065] Antibodies to a NHP can, in turn, be utilized to generate anti-idiotype antibodies that “mimic” a given NHP, using techniques well known to those skilled in the art. (See, e.g., Greenspan & Bona, 1993, FASEB J 7(5):437-444; and Nissinoff, 1991, J. Immunol. 147(8):2429-2438). For example antibodies which bind to a NHP domain and competitively inhibit the binding of NHP to its cognate receptor can be used to generate anti-idiotypes that “mimic” the NHP and, therefore, bind and activate or neutralize a receptor. Such anti-idiotypic antibodies or Fab fragments of such anti-idiotypes can be used in therapeutic regimens involving a NHP mediated pathway.

[0066] The present invention is not to be limited in scope by the specific embodiments described herein, which are intended as single illustrations of individual aspects of the invention, and functionally equivalent methods and components are within the scope of the invention. Indeed, various modifications of the invention, in addition to those shown and described herein will become apparent to those skilled in the art from the foregoing description. Such modifications are intended to fall within the scope of the appended claims. All cited publications, patents, and patent applications are herein incorporated by reference in their entirety.

1 43 1 489 DNA homo sapiens 1 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttgctgtag 489 2 162 PRT homo sapiens 2 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Leu 3 87 DNA homo sapiens 3 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt gctgtag 87 4 28 PRT homo sapiens 4 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Leu 20 25 5 837 DNA homo sapiens 5 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgaga caaacacttg aaggatctac tgtctaa 837 6 278 PRT homo sapiens 6 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Arg Gln Thr 260 265 270 Leu Glu Gly Ser Thr Val 275 7 3129 DNA homo sapiens 7 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggtattta acgttaatgc acctctgcct ccacgaaaag aacaagaaat aaaagaatcc 2100 ccttattcac ctggctacaa tcaaagtttt accacagcaa gtacacaaac accaccccag 2160 tgccaactgc catctataca tgtagaacaa actgtccatt ctcaagagac tgcagcaaat 2220 tatcatcctg atggaactat tcaagtaagc aatggtagcc ttgcctttta cccagcacag 2280 acgaatgtgt ttcccagacc tactcagcca tttgtcaata gccggggatc tgttagagga 2340 tgtactcgtg gtgggagatt aataaccaat tcctatcggt cccctggtgg ttataaaggt 2400 tttgatactt atagaggact cccttcaatt tccaatggaa attatagcca gctgcagttc 2460 caagctagag agtattctgg agcaccttat tcccaaaggg ataatttcca gcagtgttat 2520 aagcgaggag ggacatctgg tggtccacga gcaaattcga gagggtggag tgattcttct 2580 caggtgagca gcccagaaag agacaacgaa acctttaaca gtggtgactc tggacaagga 2640 gactcccgta gcatgacccc tgtggatgtg ccagtgacaa atccagcagc caccatactg 2700 ccagtacacg tctaccctct gcctcagcag atgcgagttg ccttctcagc agccagaacc 2760 tctaatctgg cccctggaac tttagaccaa cctattgtgt ttgatcttct tctgaacaac 2820 ttaggagaaa cttttgatct tcagcttggt agatttaatt gcccagtgaa tggcacttac 2880 gttttcattt ttcacatgct aaagctggca gtgaatgtgc cactgtatgt caacctcatg 2940 aagaatgaag aggtcttggt atcagcctat gccaatgatg gtgctccaga ccatgaaact 3000 gctagcaatc atgcaattct tcagctcttc cagggagacc agatatggtt acgtctgcac 3060 aggggagcaa tttatggaag tagctggaaa tattctacgt tttcaggcta tcttctttat 3120 caagattga 3129 8 1042 PRT homo sapiens 8 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Val Phe Asn Val Asn Ala Pro 675 680 685 Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro 690 695 700 Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln 705 710 715 720 Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln Glu 725 730 735 Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly 740 745 750 Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr 755 760 765 Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly 770 775 780 Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly 785 790 795 800 Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser 805 810 815 Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln 820 825 830 Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly 835 840 845 Pro Arg Ala Asn Ser Arg Gly Trp Ser Asp Ser Ser Gln Val Ser Ser 850 855 860 Pro Glu Arg Asp Asn Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln Gly 865 870 875 880 Asp Ser Arg Ser Met Thr Pro Val Asp Val Pro Val Thr Asn Pro Ala 885 890 895 Ala Thr Ile Leu Pro Val His Val Tyr Pro Leu Pro Gln Gln Met Arg 900 905 910 Val Ala Phe Ser Ala Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr Leu 915 920 925 Asp Gln Pro Ile Val Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu Thr 930 935 940 Phe Asp Leu Gln Leu Gly Arg Phe Asn Cys Pro Val Asn Gly Thr Tyr 945 950 955 960 Val Phe Ile Phe His Met Leu Lys Leu Ala Val Asn Val Pro Leu Tyr 965 970 975 Val Asn Leu Met Lys Asn Glu Glu Val Leu Val Ser Ala Tyr Ala Asn 980 985 990 Asp Gly Ala Pro Asp His Glu Thr Ala Ser Asn His Ala Ile Leu Gln 995 1000 1005 Leu Phe Gln Gly Asp Gln Ile Trp Leu Arg Leu His Arg Gly Ala Ile 1010 1015 1020 Tyr Gly Ser Ser Trp Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu Tyr 1025 1030 1035 1040 Gln Asp 9 2727 DNA homo sapiens 9 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggtatttaac gttaatgcac ctctgcctcc acgaaaagaa 1680 caagaaataa aagaatcccc ttattcacct ggctacaatc aaagttttac cacagcaagt 1740 acacaaacac caccccagtg ccaactgcca tctatacatg tagaacaaac tgtccattct 1800 caagagactg cagcaaatta tcatcctgat ggaactattc aagtaagcaa tggtagcctt 1860 gccttttacc cagcacagac gaatgtgttt cccagaccta ctcagccatt tgtcaatagc 1920 cggggatctg ttagaggatg tactcgtggt gggagattaa taaccaattc ctatcggtcc 1980 cctggtggtt ataaaggttt tgatacttat agaggactcc cttcaatttc caatggaaat 2040 tatagccagc tgcagttcca agctagagag tattctggag caccttattc ccaaagggat 2100 aatttccagc agtgttataa gcgaggaggg acatctggtg gtccacgagc aaattcgaga 2160 gggtggagtg attcttctca ggtgagcagc ccagaaagag acaacgaaac ctttaacagt 2220 ggtgactctg gacaaggaga ctcccgtagc atgacccctg tggatgtgcc agtgacaaat 2280 ccagcagcca ccatactgcc agtacacgtc taccctctgc ctcagcagat gcgagttgcc 2340 ttctcagcag ccagaacctc taatctggcc cctggaactt tagaccaacc tattgtgttt 2400 gatcttcttc tgaacaactt aggagaaact tttgatcttc agcttggtag atttaattgc 2460 ccagtgaatg gcacttacgt tttcattttt cacatgctaa agctggcagt gaatgtgcca 2520 ctgtatgtca acctcatgaa gaatgaagag gtcttggtat cagcctatgc caatgatggt 2580 gctccagacc atgaaactgc tagcaatcat gcaattcttc agctcttcca gggagaccag 2640 atatggttac gtctgcacag gggagcaatt tatggaagta gctggaaata ttctacgttt 2700 tcaggctatc ttctttatca agattga 2727 10 908 PRT homo sapiens 10 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Val Phe Asn Val Asn Ala Pro Leu Pro Pro Arg Lys Glu 545 550 555 560 Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr Asn Gln Ser Phe 565 570 575 Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln Leu Pro Ser Ile 580 585 590 His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala Ala Asn Tyr His 595 600 605 Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu Ala Phe Tyr Pro 610 615 620 Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro Phe Val Asn Ser 625 630 635 640 Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg Leu Ile Thr Asn 645 650 655 Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp Thr Tyr Arg Gly 660 665 670 Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu Gln Phe Gln Ala 675 680 685 Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp Asn Phe Gln Gln 690 695 700 Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg Ala Asn Ser Arg 705 710 715 720 Gly Trp Ser Asp Ser Ser Gln Val Ser Ser Pro Glu Arg Asp Asn Glu 725 730 735 Thr Phe Asn Ser Gly Asp Ser Gly Gln Gly Asp Ser Arg Ser Met Thr 740 745 750 Pro Val Asp Val Pro Val Thr Asn Pro Ala Ala Thr Ile Leu Pro Val 755 760 765 His Val Tyr Pro Leu Pro Gln Gln Met Arg Val Ala Phe Ser Ala Ala 770 775 780 Arg Thr Ser Asn Leu Ala Pro Gly Thr Leu Asp Gln Pro Ile Val Phe 785 790 795 800 Asp Leu Leu Leu Asn Asn Leu Gly Glu Thr Phe Asp Leu Gln Leu Gly 805 810 815 Arg Phe Asn Cys Pro Val Asn Gly Thr Tyr Val Phe Ile Phe His Met 820 825 830 Leu Lys Leu Ala Val Asn Val Pro Leu Tyr Val Asn Leu Met Lys Asn 835 840 845 Glu Glu Val Leu Val Ser Ala Tyr Ala Asn Asp Gly Ala Pro Asp His 850 855 860 Glu Thr Ala Ser Asn His Ala Ile Leu Gln Leu Phe Gln Gly Asp Gln 865 870 875 880 Ile Trp Leu Arg Leu His Arg Gly Ala Ile Tyr Gly Ser Ser Trp Lys 885 890 895 Tyr Ser Thr Phe Ser Gly Tyr Leu Leu Tyr Gln Asp 900 905 11 3276 DNA homo sapiens 11 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggcagcaa ttcccccagg caagcaaccg tcttcactag cttctccaaa tcctcccatg 2100 gcaaagggct ctgaacaggg cttccagtca cctccagcaa gtagtagttc agtaaccatt 2160 aacacagcac cctttcaagc catgcagaca gtatttaacg ttaatgcacc tctgcctcca 2220 cgaaaagaac aagaaataaa agaatcccct tattcacctg gctacaatca aagttttacc 2280 acagcaagta cacaaacacc accccagtgc caactgccat ctatacatgt agaacaaact 2340 gtccattctc aagagactgc agcaaattat catcctgatg gaactattca agtaagcaat 2400 ggtagccttg ccttttaccc agcacagacg aatgtgtttc ccagacctac tcagccattt 2460 gtcaatagcc ggggatctgt tagaggatgt actcgtggtg ggagattaat aaccaattcc 2520 tatcggtccc ctggtggtta taaaggtttt gatacttata gaggactccc ttcaatttcc 2580 aatggaaatt atagccagct gcagttccaa gctagagagt attctggagc accttattcc 2640 caaagggata atttccagca gtgttataag cgaggaggga catctggtgg tccacgagca 2700 aattcgagag ggtggagtga ttcttctcag gtgagcagcc cagaaagaga caacgaaacc 2760 tttaacagtg gtgactctgg acaaggagac tcccgtagca tgacccctgt ggatgtgcca 2820 gtgacaaatc cagcagccac catactgcca gtacacgtct accctctgcc tcagcagatg 2880 cgagttgcct tctcagcagc cagaacctct aatctggccc ctggaacttt agaccaacct 2940 attgtgtttg atcttcttct gaacaactta ggagaaactt ttgatcttca gcttggtaga 3000 tttaattgcc cagtgaatgg cacttacgtt ttcatttttc acatgctaaa gctggcagtg 3060 aatgtgccac tgtatgtcaa cctcatgaag aatgaagagg tcttggtatc agcctatgcc 3120 aatgatggtg ctccagacca tgaaactgct agcaatcatg caattcttca gctcttccag 3180 ggagaccaga tatggttacg tctgcacagg ggagcaattt atggaagtag ctggaaatat 3240 tctacgtttt caggctatct tctttatcaa gattga 3276 12 1091 PRT homo sapiens 12 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Ala Ala Ile Pro Pro Gly Lys 675 680 685 Gln Pro Ser Ser Leu Ala Ser Pro Asn Pro Pro Met Ala Lys Gly Ser 690 695 700 Glu Gln Gly Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser Val Thr Ile 705 710 715 720 Asn Thr Ala Pro Phe Gln Ala Met Gln Thr Val Phe Asn Val Asn Ala 725 730 735 Pro Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser 740 745 750 Pro Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro 755 760 765 Gln Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln 770 775 780 Glu Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn 785 790 795 800 Gly Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro 805 810 815 Thr Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg 820 825 830 Gly Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys 835 840 845 Gly Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr 850 855 860 Ser Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser 865 870 875 880 Gln Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly 885 890 895 Gly Pro Arg Ala Asn Ser Arg Gly Trp Ser Asp Ser Ser Gln Val Ser 900 905 910 Ser Pro Glu Arg Asp Asn Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln 915 920 925 Gly Asp Ser Arg Ser Met Thr Pro Val Asp Val Pro Val Thr Asn Pro 930 935 940 Ala Ala Thr Ile Leu Pro Val His Val Tyr Pro Leu Pro Gln Gln Met 945 950 955 960 Arg Val Ala Phe Ser Ala Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr 965 970 975 Leu Asp Gln Pro Ile Val Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu 980 985 990 Thr Phe Asp Leu Gln Leu Gly Arg Phe Asn Cys Pro Val Asn Gly Thr 995 1000 1005 Tyr Val Phe Ile Phe His Met Leu Lys Leu Ala Val Asn Val Pro Leu 1010 1015 1020 Tyr Val Asn Leu Met Lys Asn Glu Glu Val Leu Val Ser Ala Tyr Ala 1025 1030 1035 1040 Asn Asp Gly Ala Pro Asp His Glu Thr Ala Ser Asn His Ala Ile Leu 1045 1050 1055 Gln Leu Phe Gln Gly Asp Gln Ile Trp Leu Arg Leu His Arg Gly Ala 1060 1065 1070 Ile Tyr Gly Ser Ser Trp Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu 1075 1080 1085 Tyr Gln Asp 1090 13 2874 DNA homo sapiens 13 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggcagcaatt cccccaggca agcaaccgtc ttcactagct 1680 tctccaaatc ctcccatggc aaagggctct gaacagggct tccagtcacc tccagcaagt 1740 agtagttcag taaccattaa cacagcaccc tttcaagcca tgcagacagt atttaacgtt 1800 aatgcacctc tgcctccacg aaaagaacaa gaaataaaag aatcccctta ttcacctggc 1860 tacaatcaaa gttttaccac agcaagtaca caaacaccac cccagtgcca actgccatct 1920 atacatgtag aacaaactgt ccattctcaa gagactgcag caaattatca tcctgatgga 1980 actattcaag taagcaatgg tagccttgcc ttttacccag cacagacgaa tgtgtttccc 2040 agacctactc agccatttgt caatagccgg ggatctgtta gaggatgtac tcgtggtggg 2100 agattaataa ccaattccta tcggtcccct ggtggttata aaggttttga tacttataga 2160 ggactccctt caatttccaa tggaaattat agccagctgc agttccaagc tagagagtat 2220 tctggagcac cttattccca aagggataat ttccagcagt gttataagcg aggagggaca 2280 tctggtggtc cacgagcaaa ttcgagaggg tggagtgatt cttctcaggt gagcagccca 2340 gaaagagaca acgaaacctt taacagtggt gactctggac aaggagactc ccgtagcatg 2400 acccctgtgg atgtgccagt gacaaatcca gcagccacca tactgccagt acacgtctac 2460 cctctgcctc agcagatgcg agttgccttc tcagcagcca gaacctctaa tctggcccct 2520 ggaactttag accaacctat tgtgtttgat cttcttctga acaacttagg agaaactttt 2580 gatcttcagc ttggtagatt taattgccca gtgaatggca cttacgtttt catttttcac 2640 atgctaaagc tggcagtgaa tgtgccactg tatgtcaacc tcatgaagaa tgaagaggtc 2700 ttggtatcag cctatgccaa tgatggtgct ccagaccatg aaactgctag caatcatgca 2760 attcttcagc tcttccaggg agaccagata tggttacgtc tgcacagggg agcaatttat 2820 ggaagtagct ggaaatattc tacgttttca ggctatcttc tttatcaaga ttga 2874 14 957 PRT homo sapiens 14 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Ala Ala Ile Pro Pro Gly Lys Gln Pro Ser Ser Leu Ala 545 550 555 560 Ser Pro Asn Pro Pro Met Ala Lys Gly Ser Glu Gln Gly Phe Gln Ser 565 570 575 Pro Pro Ala Ser Ser Ser Ser Val Thr Ile Asn Thr Ala Pro Phe Gln 580 585 590 Ala Met Gln Thr Val Phe Asn Val Asn Ala Pro Leu Pro Pro Arg Lys 595 600 605 Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr Asn Gln Ser 610 615 620 Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln Leu Pro Ser 625 630 635 640 Ile His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala Ala Asn Tyr 645 650 655 His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu Ala Phe Tyr 660 665 670 Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro Phe Val Asn 675 680 685 Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg Leu Ile Thr 690 695 700 Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp Thr Tyr Arg 705 710 715 720 Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu Gln Phe Gln 725 730 735 Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp Asn Phe Gln 740 745 750 Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg Ala Asn Ser 755 760 765 Arg Gly Trp Ser Asp Ser Ser Gln Val Ser Ser Pro Glu Arg Asp Asn 770 775 780 Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln Gly Asp Ser Arg Ser Met 785 790 795 800 Thr Pro Val Asp Val Pro Val Thr Asn Pro Ala Ala Thr Ile Leu Pro 805 810 815 Val His Val Tyr Pro Leu Pro Gln Gln Met Arg Val Ala Phe Ser Ala 820 825 830 Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr Leu Asp Gln Pro Ile Val 835 840 845 Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu Thr Phe Asp Leu Gln Leu 850 855 860 Gly Arg Phe Asn Cys Pro Val Asn Gly Thr Tyr Val Phe Ile Phe His 865 870 875 880 Met Leu Lys Leu Ala Val Asn Val Pro Leu Tyr Val Asn Leu Met Lys 885 890 895 Asn Glu Glu Val Leu Val Ser Ala Tyr Ala Asn Asp Gly Ala Pro Asp 900 905 910 His Glu Thr Ala Ser Asn His Ala Ile Leu Gln Leu Phe Gln Gly Asp 915 920 925 Gln Ile Trp Leu Arg Leu His Arg Gly Ala Ile Tyr Gly Ser Ser Trp 930 935 940 Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu Tyr Gln Asp 945 950 955 15 3381 DNA homo sapiens 15 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggctactt cttctccagt tacttgtagc tcaaatgctt gcttggttac taccgatcag 2100 gcttcttctg gatctgaaac agagtttatg acctcagaga ctcctgaggc agcaattccc 2160 ccaggcaagc aaccgtcttc actagcttct ccaaatcctc ccatggcaaa gggctctgaa 2220 cagggcttcc agtcacctcc agcaagtagt agttcagtaa ccattaacac agcacccttt 2280 caagccatgc agacagtatt taacgttaat gcacctctgc ctccacgaaa agaacaagaa 2340 ataaaagaat ccccttattc acctggctac aatcaaagtt ttaccacagc aagtacacaa 2400 acaccacccc agtgccaact gccatctata catgtagaac aaactgtcca ttctcaagag 2460 actgcagcaa attatcatcc tgatggaact attcaagtaa gcaatggtag ccttgccttt 2520 tacccagcac agacgaatgt gtttcccaga cctactcagc catttgtcaa tagccgggga 2580 tctgttagag gatgtactcg tggtgggaga ttaataacca attcctatcg gtcccctggt 2640 ggttataaag gttttgatac ttatagagga ctcccttcaa tttccaatgg aaattatagc 2700 cagctgcagt tccaagctag agagtattct ggagcacctt attcccaaag ggataatttc 2760 cagcagtgtt ataagcgagg agggacatct ggtggtccac gagcaaattc gagagggtgg 2820 agtgattctt ctcaggtgag cagcccagaa agagacaacg aaacctttaa cagtggtgac 2880 tctggacaag gagactcccg tagcatgacc cctgtggatg tgccagtgac aaatccagca 2940 gccaccatac tgccagtaca cgtctaccct ctgcctcagc agatgcgagt tgccttctca 3000 gcagccagaa cctctaatct ggcccctgga actttagacc aacctattgt gtttgatctt 3060 cttctgaaca acttaggaga aacttttgat cttcagcttg gtagatttaa ttgcccagtg 3120 aatggcactt acgttttcat ttttcacatg ctaaagctgg cagtgaatgt gccactgtat 3180 gtcaacctca tgaagaatga agaggtcttg gtatcagcct atgccaatga tggtgctcca 3240 gaccatgaaa ctgctagcaa tcatgcaatt cttcagctct tccagggaga ccagatatgg 3300 ttacgtctgc acaggggagc aatttatgga agtagctgga aatattctac gttttcaggc 3360 tatcttcttt atcaagattg a 3381 16 1126 PRT homo sapiens 16 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Ala Thr Ser Ser Pro Val Thr 675 680 685 Cys Ser Ser Asn Ala Cys Leu Val Thr Thr Asp Gln Ala Ser Ser Gly 690 695 700 Ser Glu Thr Glu Phe Met Thr Ser Glu Thr Pro Glu Ala Ala Ile Pro 705 710 715 720 Pro Gly Lys Gln Pro Ser Ser Leu Ala Ser Pro Asn Pro Pro Met Ala 725 730 735 Lys Gly Ser Glu Gln Gly Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser 740 745 750 Val Thr Ile Asn Thr Ala Pro Phe Gln Ala Met Gln Thr Val Phe Asn 755 760 765 Val Asn Ala Pro Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser 770 775 780 Pro Tyr Ser Pro Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln 785 790 795 800 Thr Pro Pro Gln Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val 805 810 815 His Ser Gln Glu Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln 820 825 830 Val Ser Asn Gly Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe 835 840 845 Pro Arg Pro Thr Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly 850 855 860 Cys Thr Arg Gly Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly 865 870 875 880 Gly Tyr Lys Gly Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn 885 890 895 Gly Asn Tyr Ser Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala 900 905 910 Pro Tyr Ser Gln Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly 915 920 925 Thr Ser Gly Gly Pro Arg Ala Asn Ser Arg Gly Trp Ser Asp Ser Ser 930 935 940 Gln Val Ser Ser Pro Glu Arg Asp Asn Glu Thr Phe Asn Ser Gly Asp 945 950 955 960 Ser Gly Gln Gly Asp Ser Arg Ser Met Thr Pro Val Asp Val Pro Val 965 970 975 Thr Asn Pro Ala Ala Thr Ile Leu Pro Val His Val Tyr Pro Leu Pro 980 985 990 Gln Gln Met Arg Val Ala Phe Ser Ala Ala Arg Thr Ser Asn Leu Ala 995 1000 1005 Pro Gly Thr Leu Asp Gln Pro Ile Val Phe Asp Leu Leu Leu Asn Asn 1010 1015 1020 Leu Gly Glu Thr Phe Asp Leu Gln Leu Gly Arg Phe Asn Cys Pro Val 1025 1030 1035 1040 Asn Gly Thr Tyr Val Phe Ile Phe His Met Leu Lys Leu Ala Val Asn 1045 1050 1055 Val Pro Leu Tyr Val Asn Leu Met Lys Asn Glu Glu Val Leu Val Ser 1060 1065 1070 Ala Tyr Ala Asn Asp Gly Ala Pro Asp His Glu Thr Ala Ser Asn His 1075 1080 1085 Ala Ile Leu Gln Leu Phe Gln Gly Asp Gln Ile Trp Leu Arg Leu His 1090 1095 1100 Arg Gly Ala Ile Tyr Gly Ser Ser Trp Lys Tyr Ser Thr Phe Ser Gly 1105 1110 1115 1120 Tyr Leu Leu Tyr Gln Asp 1125 17 2979 DNA homo sapiens 17 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggctacttct tctccagtta cttgtagctc aaatgcttgc 1680 ttggttacta ccgatcaggc ttcttctgga tctgaaacag agtttatgac ctcagagact 1740 cctgaggcag caattccccc aggcaagcaa ccgtcttcac tagcttctcc aaatcctccc 1800 atggcaaagg gctctgaaca gggcttccag tcacctccag caagtagtag ttcagtaacc 1860 attaacacag caccctttca agccatgcag acagtattta acgttaatgc acctctgcct 1920 ccacgaaaag aacaagaaat aaaagaatcc ccttattcac ctggctacaa tcaaagtttt 1980 accacagcaa gtacacaaac accaccccag tgccaactgc catctataca tgtagaacaa 2040 actgtccatt ctcaagagac tgcagcaaat tatcatcctg atggaactat tcaagtaagc 2100 aatggtagcc ttgcctttta cccagcacag acgaatgtgt ttcccagacc tactcagcca 2160 tttgtcaata gccggggatc tgttagagga tgtactcgtg gtgggagatt aataaccaat 2220 tcctatcggt cccctggtgg ttataaaggt tttgatactt atagaggact cccttcaatt 2280 tccaatggaa attatagcca gctgcagttc caagctagag agtattctgg agcaccttat 2340 tcccaaaggg ataatttcca gcagtgttat aagcgaggag ggacatctgg tggtccacga 2400 gcaaattcga gagggtggag tgattcttct caggtgagca gcccagaaag agacaacgaa 2460 acctttaaca gtggtgactc tggacaagga gactcccgta gcatgacccc tgtggatgtg 2520 ccagtgacaa atccagcagc caccatactg ccagtacacg tctaccctct gcctcagcag 2580 atgcgagttg ccttctcagc agccagaacc tctaatctgg cccctggaac tttagaccaa 2640 cctattgtgt ttgatcttct tctgaacaac ttaggagaaa cttttgatct tcagcttggt 2700 agatttaatt gcccagtgaa tggcacttac gttttcattt ttcacatgct aaagctggca 2760 gtgaatgtgc cactgtatgt caacctcatg aagaatgaag aggtcttggt atcagcctat 2820 gccaatgatg gtgctccaga ccatgaaact gctagcaatc atgcaattct tcagctcttc 2880 cagggagacc agatatggtt acgtctgcac aggggagcaa tttatggaag tagctggaaa 2940 tattctacgt tttcaggcta tcttctttat caagattga 2979 18 992 PRT homo sapiens 18 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Ala Thr Ser Ser Pro Val Thr Cys Ser Ser Asn Ala Cys 545 550 555 560 Leu Val Thr Thr Asp Gln Ala Ser Ser Gly Ser Glu Thr Glu Phe Met 565 570 575 Thr Ser Glu Thr Pro Glu Ala Ala Ile Pro Pro Gly Lys Gln Pro Ser 580 585 590 Ser Leu Ala Ser Pro Asn Pro Pro Met Ala Lys Gly Ser Glu Gln Gly 595 600 605 Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser Val Thr Ile Asn Thr Ala 610 615 620 Pro Phe Gln Ala Met Gln Thr Val Phe Asn Val Asn Ala Pro Leu Pro 625 630 635 640 Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr 645 650 655 Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln 660 665 670 Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala 675 680 685 Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu 690 695 700 Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro 705 710 715 720 Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg 725 730 735 Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp 740 745 750 Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu 755 760 765 Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp 770 775 780 Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg 785 790 795 800 Ala Asn Ser Arg Gly Trp Ser Asp Ser Ser Gln Val Ser Ser Pro Glu 805 810 815 Arg Asp Asn Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln Gly Asp Ser 820 825 830 Arg Ser Met Thr Pro Val Asp Val Pro Val Thr Asn Pro Ala Ala Thr 835 840 845 Ile Leu Pro Val His Val Tyr Pro Leu Pro Gln Gln Met Arg Val Ala 850 855 860 Phe Ser Ala Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr Leu Asp Gln 865 870 875 880 Pro Ile Val Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu Thr Phe Asp 885 890 895 Leu Gln Leu Gly Arg Phe Asn Cys Pro Val Asn Gly Thr Tyr Val Phe 900 905 910 Ile Phe His Met Leu Lys Leu Ala Val Asn Val Pro Leu Tyr Val Asn 915 920 925 Leu Met Lys Asn Glu Glu Val Leu Val Ser Ala Tyr Ala Asn Asp Gly 930 935 940 Ala Pro Asp His Glu Thr Ala Ser Asn His Ala Ile Leu Gln Leu Phe 945 950 955 960 Gln Gly Asp Gln Ile Trp Leu Arg Leu His Arg Gly Ala Ile Tyr Gly 965 970 975 Ser Ser Trp Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu Tyr Gln Asp 980 985 990 19 3132 DNA homo sapiens 19 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggtattta acgttaatgc acctctgcct ccacgaaaag aacaagaaat aaaagaatcc 2100 ccttattcac ctggctacaa tcaaagtttt accacagcaa gtacacaaac accaccccag 2160 tgccaactgc catctataca tgtagaacaa actgtccatt ctcaagagac tgcagcaaat 2220 tatcatcctg atggaactat tcaagtaagc aatggtagcc ttgcctttta cccagcacag 2280 acgaatgtgt ttcccagacc tactcagcca tttgtcaata gccggggatc tgttagagga 2340 tgtactcgtg gtgggagatt aataaccaat tcctatcggt cccctggtgg ttataaaggt 2400 tttgatactt atagaggact cccttcaatt tccaatggaa attatagcca gctgcagttc 2460 caagctagag agtattctgg agcaccttat tcccaaaggg ataatttcca gcagtgttat 2520 aagcgaggag ggacatctgg tggtccacga gcaaattcga gagcagggtg gagtgattct 2580 tctcaggtga gcagcccaga aagagacaac gaaaccttta acagtggtga ctctggacaa 2640 ggagactccc gtagcatgac ccctgtggat gtgccagtga caaatccagc agccaccata 2700 ctgccagtac acgtctaccc tctgcctcag cagatgcgag ttgccttctc agcagccaga 2760 acctctaatc tggcccctgg aactttagac caacctattg tgtttgatct tcttctgaac 2820 aacttaggag aaacttttga tcttcagctt ggtagattta attgcccagt gaatggcact 2880 tacgttttca tttttcacat gctaaagctg gcagtgaatg tgccactgta tgtcaacctc 2940 atgaagaatg aagaggtctt ggtatcagcc tatgccaatg atggtgctcc agaccatgaa 3000 actgctagca atcatgcaat tcttcagctc ttccagggag accagatatg gttacgtctg 3060 cacaggggag caatttatgg aagtagctgg aaatattcta cgttttcagg ctatcttctt 3120 tatcaagatt ga 3132 20 1043 PRT homo sapiens 20 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Val Phe Asn Val Asn Ala Pro 675 680 685 Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro 690 695 700 Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln 705 710 715 720 Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln Glu 725 730 735 Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly 740 745 750 Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr 755 760 765 Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly 770 775 780 Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly 785 790 795 800 Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser 805 810 815 Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln 820 825 830 Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly 835 840 845 Pro Arg Ala Asn Ser Arg Ala Gly Trp Ser Asp Ser Ser Gln Val Ser 850 855 860 Ser Pro Glu Arg Asp Asn Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln 865 870 875 880 Gly Asp Ser Arg Ser Met Thr Pro Val Asp Val Pro Val Thr Asn Pro 885 890 895 Ala Ala Thr Ile Leu Pro Val His Val Tyr Pro Leu Pro Gln Gln Met 900 905 910 Arg Val Ala Phe Ser Ala Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr 915 920 925 Leu Asp Gln Pro Ile Val Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu 930 935 940 Thr Phe Asp Leu Gln Leu Gly Arg Phe Asn Cys Pro Val Asn Gly Thr 945 950 955 960 Tyr Val Phe Ile Phe His Met Leu Lys Leu Ala Val Asn Val Pro Leu 965 970 975 Tyr Val Asn Leu Met Lys Asn Glu Glu Val Leu Val Ser Ala Tyr Ala 980 985 990 Asn Asp Gly Ala Pro Asp His Glu Thr Ala Ser Asn His Ala Ile Leu 995 1000 1005 Gln Leu Phe Gln Gly Asp Gln Ile Trp Leu Arg Leu His Arg Gly Ala 1010 1015 1020 Ile Tyr Gly Ser Ser Trp Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu 1025 1030 1035 1040 Tyr Gln Asp 21 2730 DNA homo sapiens 21 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggtatttaac gttaatgcac ctctgcctcc acgaaaagaa 1680 caagaaataa aagaatcccc ttattcacct ggctacaatc aaagttttac cacagcaagt 1740 acacaaacac caccccagtg ccaactgcca tctatacatg tagaacaaac tgtccattct 1800 caagagactg cagcaaatta tcatcctgat ggaactattc aagtaagcaa tggtagcctt 1860 gccttttacc cagcacagac gaatgtgttt cccagaccta ctcagccatt tgtcaatagc 1920 cggggatctg ttagaggatg tactcgtggt gggagattaa taaccaattc ctatcggtcc 1980 cctggtggtt ataaaggttt tgatacttat agaggactcc cttcaatttc caatggaaat 2040 tatagccagc tgcagttcca agctagagag tattctggag caccttattc ccaaagggat 2100 aatttccagc agtgttataa gcgaggaggg acatctggtg gtccacgagc aaattcgaga 2160 gcagggtgga gtgattcttc tcaggtgagc agcccagaaa gagacaacga aacctttaac 2220 agtggtgact ctggacaagg agactcccgt agcatgaccc ctgtggatgt gccagtgaca 2280 aatccagcag ccaccatact gccagtacac gtctaccctc tgcctcagca gatgcgagtt 2340 gccttctcag cagccagaac ctctaatctg gcccctggaa ctttagacca acctattgtg 2400 tttgatcttc ttctgaacaa cttaggagaa acttttgatc ttcagcttgg tagatttaat 2460 tgcccagtga atggcactta cgttttcatt tttcacatgc taaagctggc agtgaatgtg 2520 ccactgtatg tcaacctcat gaagaatgaa gaggtcttgg tatcagccta tgccaatgat 2580 ggtgctccag accatgaaac tgctagcaat catgcaattc ttcagctctt ccagggagac 2640 cagatatggt tacgtctgca caggggagca atttatggaa gtagctggaa atattctacg 2700 ttttcaggct atcttcttta tcaagattga 2730 22 909 PRT homo sapiens 22 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Val Phe Asn Val Asn Ala Pro Leu Pro Pro Arg Lys Glu 545 550 555 560 Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr Asn Gln Ser Phe 565 570 575 Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln Leu Pro Ser Ile 580 585 590 His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala Ala Asn Tyr His 595 600 605 Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu Ala Phe Tyr Pro 610 615 620 Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro Phe Val Asn Ser 625 630 635 640 Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg Leu Ile Thr Asn 645 650 655 Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp Thr Tyr Arg Gly 660 665 670 Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu Gln Phe Gln Ala 675 680 685 Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp Asn Phe Gln Gln 690 695 700 Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg Ala Asn Ser Arg 705 710 715 720 Ala Gly Trp Ser Asp Ser Ser Gln Val Ser Ser Pro Glu Arg Asp Asn 725 730 735 Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln Gly Asp Ser Arg Ser Met 740 745 750 Thr Pro Val Asp Val Pro Val Thr Asn Pro Ala Ala Thr Ile Leu Pro 755 760 765 Val His Val Tyr Pro Leu Pro Gln Gln Met Arg Val Ala Phe Ser Ala 770 775 780 Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr Leu Asp Gln Pro Ile Val 785 790 795 800 Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu Thr Phe Asp Leu Gln Leu 805 810 815 Gly Arg Phe Asn Cys Pro Val Asn Gly Thr Tyr Val Phe Ile Phe His 820 825 830 Met Leu Lys Leu Ala Val Asn Val Pro Leu Tyr Val Asn Leu Met Lys 835 840 845 Asn Glu Glu Val Leu Val Ser Ala Tyr Ala Asn Asp Gly Ala Pro Asp 850 855 860 His Glu Thr Ala Ser Asn His Ala Ile Leu Gln Leu Phe Gln Gly Asp 865 870 875 880 Gln Ile Trp Leu Arg Leu His Arg Gly Ala Ile Tyr Gly Ser Ser Trp 885 890 895 Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu Tyr Gln Asp 900 905 23 3279 DNA homo sapiens 23 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggcagcaa ttcccccagg caagcaaccg tcttcactag cttctccaaa tcctcccatg 2100 gcaaagggct ctgaacaggg cttccagtca cctccagcaa gtagtagttc agtaaccatt 2160 aacacagcac cctttcaagc catgcagaca gtatttaacg ttaatgcacc tctgcctcca 2220 cgaaaagaac aagaaataaa agaatcccct tattcacctg gctacaatca aagttttacc 2280 acagcaagta cacaaacacc accccagtgc caactgccat ctatacatgt agaacaaact 2340 gtccattctc aagagactgc agcaaattat catcctgatg gaactattca agtaagcaat 2400 ggtagccttg ccttttaccc agcacagacg aatgtgtttc ccagacctac tcagccattt 2460 gtcaatagcc ggggatctgt tagaggatgt actcgtggtg ggagattaat aaccaattcc 2520 tatcggtccc ctggtggtta taaaggtttt gatacttata gaggactccc ttcaatttcc 2580 aatggaaatt atagccagct gcagttccaa gctagagagt attctggagc accttattcc 2640 caaagggata atttccagca gtgttataag cgaggaggga catctggtgg tccacgagca 2700 aattcgagag cagggtggag tgattcttct caggtgagca gcccagaaag agacaacgaa 2760 acctttaaca gtggtgactc tggacaagga gactcccgta gcatgacccc tgtggatgtg 2820 ccagtgacaa atccagcagc caccatactg ccagtacacg tctaccctct gcctcagcag 2880 atgcgagttg ccttctcagc agccagaacc tctaatctgg cccctggaac tttagaccaa 2940 cctattgtgt ttgatcttct tctgaacaac ttaggagaaa cttttgatct tcagcttggt 3000 agatttaatt gcccagtgaa tggcacttac gttttcattt ttcacatgct aaagctggca 3060 gtgaatgtgc cactgtatgt caacctcatg aagaatgaag aggtcttggt atcagcctat 3120 gccaatgatg gtgctccaga ccatgaaact gctagcaatc atgcaattct tcagctcttc 3180 cagggagacc agatatggtt acgtctgcac aggggagcaa tttatggaag tagctggaaa 3240 tattctacgt tttcaggcta tcttctttat caagattga 3279 24 1092 PRT homo sapiens 24 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Ala Ala Ile Pro Pro Gly Lys 675 680 685 Gln Pro Ser Ser Leu Ala Ser Pro Asn Pro Pro Met Ala Lys Gly Ser 690 695 700 Glu Gln Gly Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser Val Thr Ile 705 710 715 720 Asn Thr Ala Pro Phe Gln Ala Met Gln Thr Val Phe Asn Val Asn Ala 725 730 735 Pro Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser 740 745 750 Pro Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro 755 760 765 Gln Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln 770 775 780 Glu Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn 785 790 795 800 Gly Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro 805 810 815 Thr Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg 820 825 830 Gly Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys 835 840 845 Gly Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr 850 855 860 Ser Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser 865 870 875 880 Gln Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly 885 890 895 Gly Pro Arg Ala Asn Ser Arg Ala Gly Trp Ser Asp Ser Ser Gln Val 900 905 910 Ser Ser Pro Glu Arg Asp Asn Glu Thr Phe Asn Ser Gly Asp Ser Gly 915 920 925 Gln Gly Asp Ser Arg Ser Met Thr Pro Val Asp Val Pro Val Thr Asn 930 935 940 Pro Ala Ala Thr Ile Leu Pro Val His Val Tyr Pro Leu Pro Gln Gln 945 950 955 960 Met Arg Val Ala Phe Ser Ala Ala Arg Thr Ser Asn Leu Ala Pro Gly 965 970 975 Thr Leu Asp Gln Pro Ile Val Phe Asp Leu Leu Leu Asn Asn Leu Gly 980 985 990 Glu Thr Phe Asp Leu Gln Leu Gly Arg Phe Asn Cys Pro Val Asn Gly 995 1000 1005 Thr Tyr Val Phe Ile Phe His Met Leu Lys Leu Ala Val Asn Val Pro 1010 1015 1020 Leu Tyr Val Asn Leu Met Lys Asn Glu Glu Val Leu Val Ser Ala Tyr 1025 1030 1035 1040 Ala Asn Asp Gly Ala Pro Asp His Glu Thr Ala Ser Asn His Ala Ile 1045 1050 1055 Leu Gln Leu Phe Gln Gly Asp Gln Ile Trp Leu Arg Leu His Arg Gly 1060 1065 1070 Ala Ile Tyr Gly Ser Ser Trp Lys Tyr Ser Thr Phe Ser Gly Tyr Leu 1075 1080 1085 Leu Tyr Gln Asp 1090 25 2877 DNA homo sapiens 25 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggcagcaatt cccccaggca agcaaccgtc ttcactagct 1680 tctccaaatc ctcccatggc aaagggctct gaacagggct tccagtcacc tccagcaagt 1740 agtagttcag taaccattaa cacagcaccc tttcaagcca tgcagacagt atttaacgtt 1800 aatgcacctc tgcctccacg aaaagaacaa gaaataaaag aatcccctta ttcacctggc 1860 tacaatcaaa gttttaccac agcaagtaca caaacaccac cccagtgcca actgccatct 1920 atacatgtag aacaaactgt ccattctcaa gagactgcag caaattatca tcctgatgga 1980 actattcaag taagcaatgg tagccttgcc ttttacccag cacagacgaa tgtgtttccc 2040 agacctactc agccatttgt caatagccgg ggatctgtta gaggatgtac tcgtggtggg 2100 agattaataa ccaattccta tcggtcccct ggtggttata aaggttttga tacttataga 2160 ggactccctt caatttccaa tggaaattat agccagctgc agttccaagc tagagagtat 2220 tctggagcac cttattccca aagggataat ttccagcagt gttataagcg aggagggaca 2280 tctggtggtc cacgagcaaa ttcgagagca gggtggagtg attcttctca ggtgagcagc 2340 ccagaaagag acaacgaaac ctttaacagt ggtgactctg gacaaggaga ctcccgtagc 2400 atgacccctg tggatgtgcc agtgacaaat ccagcagcca ccatactgcc agtacacgtc 2460 taccctctgc ctcagcagat gcgagttgcc ttctcagcag ccagaacctc taatctggcc 2520 cctggaactt tagaccaacc tattgtgttt gatcttcttc tgaacaactt aggagaaact 2580 tttgatcttc agcttggtag atttaattgc ccagtgaatg gcacttacgt tttcattttt 2640 cacatgctaa agctggcagt gaatgtgcca ctgtatgtca acctcatgaa gaatgaagag 2700 gtcttggtat cagcctatgc caatgatggt gctccagacc atgaaactgc tagcaatcat 2760 gcaattcttc agctcttcca gggagaccag atatggttac gtctgcacag gggagcaatt 2820 tatggaagta gctggaaata ttctacgttt tcaggctatc ttctttatca agattga 2877 26 958 PRT homo sapiens 26 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Ala Ala Ile Pro Pro Gly Lys Gln Pro Ser Ser Leu Ala 545 550 555 560 Ser Pro Asn Pro Pro Met Ala Lys Gly Ser Glu Gln Gly Phe Gln Ser 565 570 575 Pro Pro Ala Ser Ser Ser Ser Val Thr Ile Asn Thr Ala Pro Phe Gln 580 585 590 Ala Met Gln Thr Val Phe Asn Val Asn Ala Pro Leu Pro Pro Arg Lys 595 600 605 Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr Asn Gln Ser 610 615 620 Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln Leu Pro Ser 625 630 635 640 Ile His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala Ala Asn Tyr 645 650 655 His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu Ala Phe Tyr 660 665 670 Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro Phe Val Asn 675 680 685 Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg Leu Ile Thr 690 695 700 Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp Thr Tyr Arg 705 710 715 720 Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu Gln Phe Gln 725 730 735 Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp Asn Phe Gln 740 745 750 Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg Ala Asn Ser 755 760 765 Arg Ala Gly Trp Ser Asp Ser Ser Gln Val Ser Ser Pro Glu Arg Asp 770 775 780 Asn Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln Gly Asp Ser Arg Ser 785 790 795 800 Met Thr Pro Val Asp Val Pro Val Thr Asn Pro Ala Ala Thr Ile Leu 805 810 815 Pro Val His Val Tyr Pro Leu Pro Gln Gln Met Arg Val Ala Phe Ser 820 825 830 Ala Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr Leu Asp Gln Pro Ile 835 840 845 Val Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu Thr Phe Asp Leu Gln 850 855 860 Leu Gly Arg Phe Asn Cys Pro Val Asn Gly Thr Tyr Val Phe Ile Phe 865 870 875 880 His Met Leu Lys Leu Ala Val Asn Val Pro Leu Tyr Val Asn Leu Met 885 890 895 Lys Asn Glu Glu Val Leu Val Ser Ala Tyr Ala Asn Asp Gly Ala Pro 900 905 910 Asp His Glu Thr Ala Ser Asn His Ala Ile Leu Gln Leu Phe Gln Gly 915 920 925 Asp Gln Ile Trp Leu Arg Leu His Arg Gly Ala Ile Tyr Gly Ser Ser 930 935 940 Trp Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu Tyr Gln Asp 945 950 955 27 3384 DNA homo sapiens 27 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggctactt cttctccagt tacttgtagc tcaaatgctt gcttggttac taccgatcag 2100 gcttcttctg gatctgaaac agagtttatg acctcagaga ctcctgaggc agcaattccc 2160 ccaggcaagc aaccgtcttc actagcttct ccaaatcctc ccatggcaaa gggctctgaa 2220 cagggcttcc agtcacctcc agcaagtagt agttcagtaa ccattaacac agcacccttt 2280 caagccatgc agacagtatt taacgttaat gcacctctgc ctccacgaaa agaacaagaa 2340 ataaaagaat ccccttattc acctggctac aatcaaagtt ttaccacagc aagtacacaa 2400 acaccacccc agtgccaact gccatctata catgtagaac aaactgtcca ttctcaagag 2460 actgcagcaa attatcatcc tgatggaact attcaagtaa gcaatggtag ccttgccttt 2520 tacccagcac agacgaatgt gtttcccaga cctactcagc catttgtcaa tagccgggga 2580 tctgttagag gatgtactcg tggtgggaga ttaataacca attcctatcg gtcccctggt 2640 ggttataaag gttttgatac ttatagagga ctcccttcaa tttccaatgg aaattatagc 2700 cagctgcagt tccaagctag agagtattct ggagcacctt attcccaaag ggataatttc 2760 cagcagtgtt ataagcgagg agggacatct ggtggtccac gagcaaattc gagagcaggg 2820 tggagtgatt cttctcaggt gagcagccca gaaagagaca acgaaacctt taacagtggt 2880 gactctggac aaggagactc ccgtagcatg acccctgtgg atgtgccagt gacaaatcca 2940 gcagccacca tactgccagt acacgtctac cctctgcctc agcagatgcg agttgccttc 3000 tcagcagcca gaacctctaa tctggcccct ggaactttag accaacctat tgtgtttgat 3060 cttcttctga acaacttagg agaaactttt gatcttcagc ttggtagatt taattgccca 3120 gtgaatggca cttacgtttt catttttcac atgctaaagc tggcagtgaa tgtgccactg 3180 tatgtcaacc tcatgaagaa tgaagaggtc ttggtatcag cctatgccaa tgatggtgct 3240 ccagaccatg aaactgctag caatcatgca attcttcagc tcttccaggg agaccagata 3300 tggttacgtc tgcacagggg agcaatttat ggaagtagct ggaaatattc tacgttttca 3360 ggctatcttc tttatcaaga ttga 3384 28 1127 PRT homo sapiens 28 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Ala Thr Ser Ser Pro Val Thr 675 680 685 Cys Ser Ser Asn Ala Cys Leu Val Thr Thr Asp Gln Ala Ser Ser Gly 690 695 700 Ser Glu Thr Glu Phe Met Thr Ser Glu Thr Pro Glu Ala Ala Ile Pro 705 710 715 720 Pro Gly Lys Gln Pro Ser Ser Leu Ala Ser Pro Asn Pro Pro Met Ala 725 730 735 Lys Gly Ser Glu Gln Gly Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser 740 745 750 Val Thr Ile Asn Thr Ala Pro Phe Gln Ala Met Gln Thr Val Phe Asn 755 760 765 Val Asn Ala Pro Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser 770 775 780 Pro Tyr Ser Pro Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln 785 790 795 800 Thr Pro Pro Gln Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val 805 810 815 His Ser Gln Glu Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln 820 825 830 Val Ser Asn Gly Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe 835 840 845 Pro Arg Pro Thr Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly 850 855 860 Cys Thr Arg Gly Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly 865 870 875 880 Gly Tyr Lys Gly Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn 885 890 895 Gly Asn Tyr Ser Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala 900 905 910 Pro Tyr Ser Gln Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly 915 920 925 Thr Ser Gly Gly Pro Arg Ala Asn Ser Arg Ala Gly Trp Ser Asp Ser 930 935 940 Ser Gln Val Ser Ser Pro Glu Arg Asp Asn Glu Thr Phe Asn Ser Gly 945 950 955 960 Asp Ser Gly Gln Gly Asp Ser Arg Ser Met Thr Pro Val Asp Val Pro 965 970 975 Val Thr Asn Pro Ala Ala Thr Ile Leu Pro Val His Val Tyr Pro Leu 980 985 990 Pro Gln Gln Met Arg Val Ala Phe Ser Ala Ala Arg Thr Ser Asn Leu 995 1000 1005 Ala Pro Gly Thr Leu Asp Gln Pro Ile Val Phe Asp Leu Leu Leu Asn 1010 1015 1020 Asn Leu Gly Glu Thr Phe Asp Leu Gln Leu Gly Arg Phe Asn Cys Pro 1025 1030 1035 1040 Val Asn Gly Thr Tyr Val Phe Ile Phe His Met Leu Lys Leu Ala Val 1045 1050 1055 Asn Val Pro Leu Tyr Val Asn Leu Met Lys Asn Glu Glu Val Leu Val 1060 1065 1070 Ser Ala Tyr Ala Asn Asp Gly Ala Pro Asp His Glu Thr Ala Ser Asn 1075 1080 1085 His Ala Ile Leu Gln Leu Phe Gln Gly Asp Gln Ile Trp Leu Arg Leu 1090 1095 1100 His Arg Gly Ala Ile Tyr Gly Ser Ser Trp Lys Tyr Ser Thr Phe Ser 1105 1110 1115 1120 Gly Tyr Leu Leu Tyr Gln Asp 1125 29 2982 DNA homo sapiens 29 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggctacttct tctccagtta cttgtagctc aaatgcttgc 1680 ttggttacta ccgatcaggc ttcttctgga tctgaaacag agtttatgac ctcagagact 1740 cctgaggcag caattccccc aggcaagcaa ccgtcttcac tagcttctcc aaatcctccc 1800 atggcaaagg gctctgaaca gggcttccag tcacctccag caagtagtag ttcagtaacc 1860 attaacacag caccctttca agccatgcag acagtattta acgttaatgc acctctgcct 1920 ccacgaaaag aacaagaaat aaaagaatcc ccttattcac ctggctacaa tcaaagtttt 1980 accacagcaa gtacacaaac accaccccag tgccaactgc catctataca tgtagaacaa 2040 actgtccatt ctcaagagac tgcagcaaat tatcatcctg atggaactat tcaagtaagc 2100 aatggtagcc ttgcctttta cccagcacag acgaatgtgt ttcccagacc tactcagcca 2160 tttgtcaata gccggggatc tgttagagga tgtactcgtg gtgggagatt aataaccaat 2220 tcctatcggt cccctggtgg ttataaaggt tttgatactt atagaggact cccttcaatt 2280 tccaatggaa attatagcca gctgcagttc caagctagag agtattctgg agcaccttat 2340 tcccaaaggg ataatttcca gcagtgttat aagcgaggag ggacatctgg tggtccacga 2400 gcaaattcga gagcagggtg gagtgattct tctcaggtga gcagcccaga aagagacaac 2460 gaaaccttta acagtggtga ctctggacaa ggagactccc gtagcatgac ccctgtggat 2520 gtgccagtga caaatccagc agccaccata ctgccagtac acgtctaccc tctgcctcag 2580 cagatgcgag ttgccttctc agcagccaga acctctaatc tggcccctgg aactttagac 2640 caacctattg tgtttgatct tcttctgaac aacttaggag aaacttttga tcttcagctt 2700 ggtagattta attgcccagt gaatggcact tacgttttca tttttcacat gctaaagctg 2760 gcagtgaatg tgccactgta tgtcaacctc atgaagaatg aagaggtctt ggtatcagcc 2820 tatgccaatg atggtgctcc agaccatgaa actgctagca atcatgcaat tcttcagctc 2880 ttccagggag accagatatg gttacgtctg cacaggggag caatttatgg aagtagctgg 2940 aaatattcta cgttttcagg ctatcttctt tatcaagatt ga 2982 30 993 PRT homo sapiens 30 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Ala Thr Ser Ser Pro Val Thr Cys Ser Ser Asn Ala Cys 545 550 555 560 Leu Val Thr Thr Asp Gln Ala Ser Ser Gly Ser Glu Thr Glu Phe Met 565 570 575 Thr Ser Glu Thr Pro Glu Ala Ala Ile Pro Pro Gly Lys Gln Pro Ser 580 585 590 Ser Leu Ala Ser Pro Asn Pro Pro Met Ala Lys Gly Ser Glu Gln Gly 595 600 605 Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser Val Thr Ile Asn Thr Ala 610 615 620 Pro Phe Gln Ala Met Gln Thr Val Phe Asn Val Asn Ala Pro Leu Pro 625 630 635 640 Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr 645 650 655 Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln 660 665 670 Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala 675 680 685 Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu 690 695 700 Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro 705 710 715 720 Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg 725 730 735 Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp 740 745 750 Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu 755 760 765 Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp 770 775 780 Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg 785 790 795 800 Ala Asn Ser Arg Ala Gly Trp Ser Asp Ser Ser Gln Val Ser Ser Pro 805 810 815 Glu Arg Asp Asn Glu Thr Phe Asn Ser Gly Asp Ser Gly Gln Gly Asp 820 825 830 Ser Arg Ser Met Thr Pro Val Asp Val Pro Val Thr Asn Pro Ala Ala 835 840 845 Thr Ile Leu Pro Val His Val Tyr Pro Leu Pro Gln Gln Met Arg Val 850 855 860 Ala Phe Ser Ala Ala Arg Thr Ser Asn Leu Ala Pro Gly Thr Leu Asp 865 870 875 880 Gln Pro Ile Val Phe Asp Leu Leu Leu Asn Asn Leu Gly Glu Thr Phe 885 890 895 Asp Leu Gln Leu Gly Arg Phe Asn Cys Pro Val Asn Gly Thr Tyr Val 900 905 910 Phe Ile Phe His Met Leu Lys Leu Ala Val Asn Val Pro Leu Tyr Val 915 920 925 Asn Leu Met Lys Asn Glu Glu Val Leu Val Ser Ala Tyr Ala Asn Asp 930 935 940 Gly Ala Pro Asp His Glu Thr Ala Ser Asn His Ala Ile Leu Gln Leu 945 950 955 960 Phe Gln Gly Asp Gln Ile Trp Leu Arg Leu His Arg Gly Ala Ile Tyr 965 970 975 Gly Ser Ser Trp Lys Tyr Ser Thr Phe Ser Gly Tyr Leu Leu Tyr Gln 980 985 990 Asp 31 2634 DNA homo sapiens 31 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggtattta acgttaatgc acctctgcct ccacgaaaag aacaagaaat aaaagaatcc 2100 ccttattcac ctggctacaa tcaaagtttt accacagcaa gtacacaaac accaccccag 2160 tgccaactgc catctataca tgtagaacaa actgtccatt ctcaagagac tgcagcaaat 2220 tatcatcctg atggaactat tcaagtaagc aatggtagcc ttgcctttta cccagcacag 2280 acgaatgtgt ttcccagacc tactcagcca tttgtcaata gccggggatc tgttagagga 2340 tgtactcgtg gtgggagatt aataaccaat tcctatcggt cccctggtgg ttataaaggt 2400 tttgatactt atagaggact cccttcaatt tccaatggaa attatagcca gctgcagttc 2460 caagctagag agtattctgg agcaccttat tcccaaaggg ataatttcca gcagtgttat 2520 aagcgaggag ggacatctgg tggtccacga gcaaattcga gagctaactg cttcattatg 2580 agaaactcac tgttgctaat aaaacagcag ggtggagtga ttcttctcag gtga 2634 32 877 PRT homo sapiens 32 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Val Phe Asn Val Asn Ala Pro 675 680 685 Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro 690 695 700 Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln 705 710 715 720 Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln Glu 725 730 735 Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly 740 745 750 Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr 755 760 765 Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly 770 775 780 Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly 785 790 795 800 Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser 805 810 815 Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln 820 825 830 Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly 835 840 845 Pro Arg Ala Asn Ser Arg Ala Asn Cys Phe Ile Met Arg Asn Ser Leu 850 855 860 Leu Leu Ile Lys Gln Gln Gly Gly Val Ile Leu Leu Arg 865 870 875 33 2232 DNA homo sapiens 33 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggtatttaac gttaatgcac ctctgcctcc acgaaaagaa 1680 caagaaataa aagaatcccc ttattcacct ggctacaatc aaagttttac cacagcaagt 1740 acacaaacac caccccagtg ccaactgcca tctatacatg tagaacaaac tgtccattct 1800 caagagactg cagcaaatta tcatcctgat ggaactattc aagtaagcaa tggtagcctt 1860 gccttttacc cagcacagac gaatgtgttt cccagaccta ctcagccatt tgtcaatagc 1920 cggggatctg ttagaggatg tactcgtggt gggagattaa taaccaattc ctatcggtcc 1980 cctggtggtt ataaaggttt tgatacttat agaggactcc cttcaatttc caatggaaat 2040 tatagccagc tgcagttcca agctagagag tattctggag caccttattc ccaaagggat 2100 aatttccagc agtgttataa gcgaggaggg acatctggtg gtccacgagc aaattcgaga 2160 gctaactgct tcattatgag aaactcactg ttgctaataa aacagcaggg tggagtgatt 2220 cttctcaggt ga 2232 34 743 PRT homo sapiens 34 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Val Phe Asn Val Asn Ala Pro Leu Pro Pro Arg Lys Glu 545 550 555 560 Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr Asn Gln Ser Phe 565 570 575 Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln Leu Pro Ser Ile 580 585 590 His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala Ala Asn Tyr His 595 600 605 Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu Ala Phe Tyr Pro 610 615 620 Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro Phe Val Asn Ser 625 630 635 640 Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg Leu Ile Thr Asn 645 650 655 Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp Thr Tyr Arg Gly 660 665 670 Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu Gln Phe Gln Ala 675 680 685 Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp Asn Phe Gln Gln 690 695 700 Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg Ala Asn Ser Arg 705 710 715 720 Ala Asn Cys Phe Ile Met Arg Asn Ser Leu Leu Leu Ile Lys Gln Gln 725 730 735 Gly Gly Val Ile Leu Leu Arg 740 35 2781 DNA homo sapiens 35 ctggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggcagcaa ttcccccagg caagcaaccg tcttcactag cttctccaaa tcctcccatg 2100 gcaaagggct ctgaacaggg cttccagtca cctccagcaa gtagtagttc agtaaccatt 2160 aacacagcac cctttcaagc catgcagaca gtatttaacg ttaatgcacc tctgcctcca 2220 cgaaaagaac aagaaataaa agaatcccct tattcacctg gctacaatca aagttttacc 2280 acagcaagta cacaaacacc accccagtgc caactgccat ctatacatgt agaacaaact 2340 gtccattctc aagagactgc agcaaattat catcctgatg gaactattca agtaagcaat 2400 ggtagccttg ccttttaccc agcacagacg aatgtgtttc ccagacctac tcagccattt 2460 gtcaatagcc ggggatctgt tagaggatgt actcgtggtg ggagattaat aaccaattcc 2520 tatcggtccc ctggtggtta taaaggtttt gatacttata gaggactccc ttcaatttcc 2580 aatggaaatt atagccagct gcagttccaa gctagagagt attctggagc accttattcc 2640 caaagggata atttccagca gtgttataag cgaggaggga catctggtgg tccacgagca 2700 aattcgagag ctaactgctt cattatgaga aactcactgt tgctaataaa acagcagggt 2760 ggagtgattc ttctcaggtg a 2781 36 926 PRT homo sapiens 36 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Ala Ala Ile Pro Pro Gly Lys 675 680 685 Gln Pro Ser Ser Leu Ala Ser Pro Asn Pro Pro Met Ala Lys Gly Ser 690 695 700 Glu Gln Gly Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser Val Thr Ile 705 710 715 720 Asn Thr Ala Pro Phe Gln Ala Met Gln Thr Val Phe Asn Val Asn Ala 725 730 735 Pro Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser 740 745 750 Pro Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro 755 760 765 Gln Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln 770 775 780 Glu Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn 785 790 795 800 Gly Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro 805 810 815 Thr Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg 820 825 830 Gly Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys 835 840 845 Gly Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr 850 855 860 Ser Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser 865 870 875 880 Gln Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly 885 890 895 Gly Pro Arg Ala Asn Ser Arg Ala Asn Cys Phe Ile Met Arg Asn Ser 900 905 910 Leu Leu Leu Ile Lys Gln Gln Gly Gly Val Ile Leu Leu Arg 915 920 925 37 2379 DNA homo sapiens 37 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggcagcaatt cccccaggca agcaaccgtc ttcactagct 1680 tctccaaatc ctcccatggc aaagggctct gaacagggct tccagtcacc tccagcaagt 1740 agtagttcag taaccattaa cacagcaccc tttcaagcca tgcagacagt atttaacgtt 1800 aatgcacctc tgcctccacg aaaagaacaa gaaataaaag aatcccctta ttcacctggc 1860 tacaatcaaa gttttaccac agcaagtaca caaacaccac cccagtgcca actgccatct 1920 atacatgtag aacaaactgt ccattctcaa gagactgcag caaattatca tcctgatgga 1980 actattcaag taagcaatgg tagccttgcc ttttacccag cacagacgaa tgtgtttccc 2040 agacctactc agccatttgt caatagccgg ggatctgtta gaggatgtac tcgtggtggg 2100 agattaataa ccaattccta tcggtcccct ggtggttata aaggttttga tacttataga 2160 ggactccctt caatttccaa tggaaattat agccagctgc agttccaagc tagagagtat 2220 tctggagcac cttattccca aagggataat ttccagcagt gttataagcg aggagggaca 2280 tctggtggtc cacgagcaaa ttcgagagct aactgcttca ttatgagaaa ctcactgttg 2340 ctaataaaac agcagggtgg agtgattctt ctcaggtga 2379 38 792 PRT homo sapiens 38 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Ala Ala Ile Pro Pro Gly Lys Gln Pro Ser Ser Leu Ala 545 550 555 560 Ser Pro Asn Pro Pro Met Ala Lys Gly Ser Glu Gln Gly Phe Gln Ser 565 570 575 Pro Pro Ala Ser Ser Ser Ser Val Thr Ile Asn Thr Ala Pro Phe Gln 580 585 590 Ala Met Gln Thr Val Phe Asn Val Asn Ala Pro Leu Pro Pro Arg Lys 595 600 605 Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr Asn Gln Ser 610 615 620 Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln Leu Pro Ser 625 630 635 640 Ile His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala Ala Asn Tyr 645 650 655 His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu Ala Phe Tyr 660 665 670 Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro Phe Val Asn 675 680 685 Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg Leu Ile Thr 690 695 700 Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp Thr Tyr Arg 705 710 715 720 Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu Gln Phe Gln 725 730 735 Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp Asn Phe Gln 740 745 750 Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg Ala Asn Ser 755 760 765 Arg Ala Asn Cys Phe Ile Met Arg Asn Ser Leu Leu Leu Ile Lys Gln 770 775 780 Gln Gly Gly Val Ile Leu Leu Arg 785 790 39 2886 DNA homo sapiens 39 atggaagtac aagtatctca agcatcattg ggtttcgagc tcacttctgt ggaaaagagt 60 ttaagggagt ggtctagact ttccagggaa gttattgcct ggctgtgtcc ctctagtcct 120 aattttatac ttaactttcc cccacctcct tcagcctcat ctgtttcaat ggtgcaactc 180 ttttcatccc cttttggtta ccagtcacct tcaggccatt cagaggagga aagagagggg 240 aatatgaagt cagccaagcc ccaagtgaac cacagtcagc atggggaaag ccagcgggcc 300 ttgagccccc tgcagtctac tctgagttct gctgcatctc cttcccaagc gtatgagacc 360 tatattgaaa atggactcat atgccttaaa cacaaaatta gaaacatcga gaaaaagaag 420 ctcaaactgg aggattataa ggatcgcctg aaaagtggag agcatcttaa tccagaccag 480 ttggaagctg tagagaaata tgaagaagtg ctacataatt tggaatttgc caaggagctt 540 caaaaaacct tttctgggtt gagcctagat ctactaaaag cgcaaaagaa ggcccagaga 600 agggagcaca tgctaaaact tgaggctgag aagaaaaagc ttcgaactat acttcaagtt 660 cagtatgtat tgcagaactt gacacaggag cacgtacaaa aagacttcaa agggggtttg 720 aatggtgcag tgtatttgcc ttcaaaagaa cttgactacc tcattaagtt ttcaaaactg 780 acctgccctg aaagaaatga aagtctgagt gttgaagacc agatggagca gtcatccttg 840 tacttttggg accttttgga aggtagtgag aaagcagtgg taggaacgac atacaaacac 900 ttgaaggatc tactgtctaa attgctgaac tcaggctatt ttgaaagtat cccagttccc 960 aaaaatgcca aggaaaagga agtaccactg gaggaagaaa tgctaataca atcagagaaa 1020 aaaacacaat tatcgaagac tgaatctgtc aaagagtcag agtctctaat ggaatttgcc 1080 cagccagaga tacaaccaca agagtttctt aacagacgct atatgacaga agtagattat 1140 tcaaacaaac aaggcgaaga gcaaccttgg gaagcagatt atgctagaaa accaaatctc 1200 ccaaaacgtt gggatatgct tactgaacca gatggtcaag agaagaaaca ggagtccttt 1260 aagtcctggg aggcttctgg taagcaccag gaggtatcca agcctgcagt ttccttagaa 1320 cagaggaaac aagacacctc aaaactcagg tctactctgc cggaagagca gaagaagcag 1380 gagatctcca aatccaagcc atctcctagc cagtggaagc aagatacacc taaatccaaa 1440 gcagggtatg ttcaagagga acaaaagaaa caggagacac caaagctgtg gccagttcag 1500 ctgcagaaag aacaagatcc aaagaagcaa actccaaagt cttggacacc ttccatgcag 1560 agcgaacaga acaccaccaa gtcatggacc actcccatgt gtgaagaaca ggattcaaaa 1620 cagccagaga ctccaaaatc ctgggaaaac aatgttgaga gtcaaaaaca ctctttaaca 1680 tcacagtcac agatttctcc aaagtcctgg ggagtagcta cagcaagcct cataccaaat 1740 gaccagctgc tgcccaggaa gttgaacaca gaacccaaag atgtgcctaa gcctgtgcat 1800 cagcctgtag gttcttcctc tacccttccg aaggatccag tattgaggaa agaaaaactg 1860 caggatctga tgactcagat tcaaggaact tgtaacttta tgcaagagtc tgttcttgac 1920 tttgacaaac cttcaagtgc aattccaacg tcacaaccgc cttcagctac tccaggtagc 1980 cccgtagcat ctaaagaaca aaatctgtcc agtcaaagtg attttcttca agagccgtta 2040 caggctactt cttctccagt tacttgtagc tcaaatgctt gcttggttac taccgatcag 2100 gcttcttctg gatctgaaac agagtttatg acctcagaga ctcctgaggc agcaattccc 2160 ccaggcaagc aaccgtcttc actagcttct ccaaatcctc ccatggcaaa gggctctgaa 2220 cagggcttcc agtcacctcc agcaagtagt agttcagtaa ccattaacac agcacccttt 2280 caagccatgc agacagtatt taacgttaat gcacctctgc ctccacgaaa agaacaagaa 2340 ataaaagaat ccccttattc acctggctac aatcaaagtt ttaccacagc aagtacacaa 2400 acaccacccc agtgccaact gccatctata catgtagaac aaactgtcca ttctcaagag 2460 actgcagcaa attatcatcc tgatggaact attcaagtaa gcaatggtag ccttgccttt 2520 tacccagcac agacgaatgt gtttcccaga cctactcagc catttgtcaa tagccgggga 2580 tctgttagag gatgtactcg tggtgggaga ttaataacca attcctatcg gtcccctggt 2640 ggttataaag gttttgatac ttatagagga ctcccttcaa tttccaatgg aaattatagc 2700 cagctgcagt tccaagctag agagtattct ggagcacctt attcccaaag ggataatttc 2760 cagcagtgtt ataagcgagg agggacatct ggtggtccac gagcaaattc gagagctaac 2820 tgcttcatta tgagaaactc actgttgcta ataaaacagc agggtggagt gattcttctc 2880 aggtga 2886 40 961 PRT homo sapiens 40 Met Glu Val Gln Val Ser Gln Ala Ser Leu Gly Phe Glu Leu Thr Ser 1 5 10 15 Val Glu Lys Ser Leu Arg Glu Trp Ser Arg Leu Ser Arg Glu Val Ile 20 25 30 Ala Trp Leu Cys Pro Ser Ser Pro Asn Phe Ile Leu Asn Phe Pro Pro 35 40 45 Pro Pro Ser Ala Ser Ser Val Ser Met Val Gln Leu Phe Ser Ser Pro 50 55 60 Phe Gly Tyr Gln Ser Pro Ser Gly His Ser Glu Glu Glu Arg Glu Gly 65 70 75 80 Asn Met Lys Ser Ala Lys Pro Gln Val Asn His Ser Gln His Gly Glu 85 90 95 Ser Gln Arg Ala Leu Ser Pro Leu Gln Ser Thr Leu Ser Ser Ala Ala 100 105 110 Ser Pro Ser Gln Ala Tyr Glu Thr Tyr Ile Glu Asn Gly Leu Ile Cys 115 120 125 Leu Lys His Lys Ile Arg Asn Ile Glu Lys Lys Lys Leu Lys Leu Glu 130 135 140 Asp Tyr Lys Asp Arg Leu Lys Ser Gly Glu His Leu Asn Pro Asp Gln 145 150 155 160 Leu Glu Ala Val Glu Lys Tyr Glu Glu Val Leu His Asn Leu Glu Phe 165 170 175 Ala Lys Glu Leu Gln Lys Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu 180 185 190 Lys Ala Gln Lys Lys Ala Gln Arg Arg Glu His Met Leu Lys Leu Glu 195 200 205 Ala Glu Lys Lys Lys Leu Arg Thr Ile Leu Gln Val Gln Tyr Val Leu 210 215 220 Gln Asn Leu Thr Gln Glu His Val Gln Lys Asp Phe Lys Gly Gly Leu 225 230 235 240 Asn Gly Ala Val Tyr Leu Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys 245 250 255 Phe Ser Lys Leu Thr Cys Pro Glu Arg Asn Glu Ser Leu Ser Val Glu 260 265 270 Asp Gln Met Glu Gln Ser Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly 275 280 285 Ser Glu Lys Ala Val Val Gly Thr Thr Tyr Lys His Leu Lys Asp Leu 290 295 300 Leu Ser Lys Leu Leu Asn Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro 305 310 315 320 Lys Asn Ala Lys Glu Lys Glu Val Pro Leu Glu Glu Glu Met Leu Ile 325 330 335 Gln Ser Glu Lys Lys Thr Gln Leu Ser Lys Thr Glu Ser Val Lys Glu 340 345 350 Ser Glu Ser Leu Met Glu Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu 355 360 365 Phe Leu Asn Arg Arg Tyr Met Thr Glu Val Asp Tyr Ser Asn Lys Gln 370 375 380 Gly Glu Glu Gln Pro Trp Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu 385 390 395 400 Pro Lys Arg Trp Asp Met Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys 405 410 415 Gln Glu Ser Phe Lys Ser Trp Glu Ala Ser Gly Lys His Gln Glu Val 420 425 430 Ser Lys Pro Ala Val Ser Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys 435 440 445 Leu Arg Ser Thr Leu Pro Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys 450 455 460 Ser Lys Pro Ser Pro Ser Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys 465 470 475 480 Ala Gly Tyr Val Gln Glu Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu 485 490 495 Trp Pro Val Gln Leu Gln Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro 500 505 510 Lys Ser Trp Thr Pro Ser Met Gln Ser Glu Gln Asn Thr Thr Lys Ser 515 520 525 Trp Thr Thr Pro Met Cys Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr 530 535 540 Pro Lys Ser Trp Glu Asn Asn Val Glu Ser Gln Lys His Ser Leu Thr 545 550 555 560 Ser Gln Ser Gln Ile Ser Pro Lys Ser Trp Gly Val Ala Thr Ala Ser 565 570 575 Leu Ile Pro Asn Asp Gln Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro 580 585 590 Lys Asp Val Pro Lys Pro Val His Gln Pro Val Gly Ser Ser Ser Thr 595 600 605 Leu Pro Lys Asp Pro Val Leu Arg Lys Glu Lys Leu Gln Asp Leu Met 610 615 620 Thr Gln Ile Gln Gly Thr Cys Asn Phe Met Gln Glu Ser Val Leu Asp 625 630 635 640 Phe Asp Lys Pro Ser Ser Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala 645 650 655 Thr Pro Gly Ser Pro Val Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln 660 665 670 Ser Asp Phe Leu Gln Glu Pro Leu Gln Ala Thr Ser Ser Pro Val Thr 675 680 685 Cys Ser Ser Asn Ala Cys Leu Val Thr Thr Asp Gln Ala Ser Ser Gly 690 695 700 Ser Glu Thr Glu Phe Met Thr Ser Glu Thr Pro Glu Ala Ala Ile Pro 705 710 715 720 Pro Gly Lys Gln Pro Ser Ser Leu Ala Ser Pro Asn Pro Pro Met Ala 725 730 735 Lys Gly Ser Glu Gln Gly Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser 740 745 750 Val Thr Ile Asn Thr Ala Pro Phe Gln Ala Met Gln Thr Val Phe Asn 755 760 765 Val Asn Ala Pro Leu Pro Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser 770 775 780 Pro Tyr Ser Pro Gly Tyr Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln 785 790 795 800 Thr Pro Pro Gln Cys Gln Leu Pro Ser Ile His Val Glu Gln Thr Val 805 810 815 His Ser Gln Glu Thr Ala Ala Asn Tyr His Pro Asp Gly Thr Ile Gln 820 825 830 Val Ser Asn Gly Ser Leu Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe 835 840 845 Pro Arg Pro Thr Gln Pro Phe Val Asn Ser Arg Gly Ser Val Arg Gly 850 855 860 Cys Thr Arg Gly Gly Arg Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly 865 870 875 880 Gly Tyr Lys Gly Phe Asp Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn 885 890 895 Gly Asn Tyr Ser Gln Leu Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala 900 905 910 Pro Tyr Ser Gln Arg Asp Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly 915 920 925 Thr Ser Gly Gly Pro Arg Ala Asn Ser Arg Ala Asn Cys Phe Ile Met 930 935 940 Arg Asn Ser Leu Leu Leu Ile Lys Gln Gln Gly Gly Val Ile Leu Leu 945 950 955 960 Arg 41 2484 DNA homo sapiens 41 atgttggctg accacaggct caaactggag gattataagg atcgcctgaa aagtggagag 60 catcttaatc cagaccagtt ggaagctgta gagaaatatg aagaagtgct acataatttg 120 gaatttgcca aggagcttca aaaaaccttt tctgggttga gcctagatct actaaaagcg 180 caaaagaagg cccagagaag ggagcacatg ctaaaacttg aggctgagaa gaaaaagctt 240 cgaactatac ttcaagttca gtatgtattg cagaacttga cacaggagca cgtacaaaaa 300 gacttcaaag ggggtttgaa tggtgcagtg tatttgcctt caaaagaact tgactacctc 360 attaagtttt caaaactgac ctgccctgaa agaaatgaaa gtctgagtgt tgaagaccag 420 atggagcagt catccttgta cttttgggac cttttggaag gtagtgagaa agcagtggta 480 ggaacgacat acaaacactt gaaggatcta ctgtctaaat tgctgaactc aggctatttt 540 gaaagtatcc cagttcccaa aaatgccaag gaaaaggaag taccactgga ggaagaaatg 600 ctaatacaat cagagaaaaa aacacaatta tcgaagactg aatctgtcaa agagtcagag 660 tctctaatgg aatttgccca gccagagata caaccacaag agtttcttaa cagacgctat 720 atgacagaag tagattattc aaacaaacaa ggcgaagagc aaccttggga agcagattat 780 gctagaaaac caaatctccc aaaacgttgg gatatgctta ctgaaccaga tggtcaagag 840 aagaaacagg agtcctttaa gtcctgggag gcttctggta agcaccagga ggtatccaag 900 cctgcagttt ccttagaaca gaggaaacaa gacacctcaa aactcaggtc tactctgccg 960 gaagagcaga agaagcagga gatctccaaa tccaagccat ctcctagcca gtggaagcaa 1020 gatacaccta aatccaaagc agggtatgtt caagaggaac aaaagaaaca ggagacacca 1080 aagctgtggc cagttcagct gcagaaagaa caagatccaa agaagcaaac tccaaagtct 1140 tggacacctt ccatgcagag cgaacagaac accaccaagt catggaccac tcccatgtgt 1200 gaagaacagg attcaaaaca gccagagact ccaaaatcct gggaaaacaa tgttgagagt 1260 caaaaacact ctttaacatc acagtcacag atttctccaa agtcctgggg agtagctaca 1320 gcaagcctca taccaaatga ccagctgctg cccaggaagt tgaacacaga acccaaagat 1380 gtgcctaagc ctgtgcatca gcctgtaggt tcttcctcta cccttccgaa ggatccagta 1440 ttgaggaaag aaaaactgca ggatctgatg actcagattc aaggaacttg taactttatg 1500 caagagtctg ttcttgactt tgacaaacct tcaagtgcaa ttccaacgtc acaaccgcct 1560 tcagctactc caggtagccc cgtagcatct aaagaacaaa atctgtccag tcaaagtgat 1620 tttcttcaag agccgttaca ggctacttct tctccagtta cttgtagctc aaatgcttgc 1680 ttggttacta ccgatcaggc ttcttctgga tctgaaacag agtttatgac ctcagagact 1740 cctgaggcag caattccccc aggcaagcaa ccgtcttcac tagcttctcc aaatcctccc 1800 atggcaaagg gctctgaaca gggcttccag tcacctccag caagtagtag ttcagtaacc 1860 attaacacag caccctttca agccatgcag acagtattta acgttaatgc acctctgcct 1920 ccacgaaaag aacaagaaat aaaagaatcc ccttattcac ctggctacaa tcaaagtttt 1980 accacagcaa gtacacaaac accaccccag tgccaactgc catctataca tgtagaacaa 2040 actgtccatt ctcaagagac tgcagcaaat tatcatcctg atggaactat tcaagtaagc 2100 aatggtagcc ttgcctttta cccagcacag acgaatgtgt ttcccagacc tactcagcca 2160 tttgtcaata gccggggatc tgttagagga tgtactcgtg gtgggagatt aataaccaat 2220 tcctatcggt cccctggtgg ttataaaggt tttgatactt atagaggact cccttcaatt 2280 tccaatggaa attatagcca gctgcagttc caagctagag agtattctgg agcaccttat 2340 tcccaaaggg ataatttcca gcagtgttat aagcgaggag ggacatctgg tggtccacga 2400 gcaaattcga gagctaactg cttcattatg agaaactcac tgttgctaat aaaacagcag 2460 ggtggagtga ttcttctcag gtga 2484 42 827 PRT homo sapiens 42 Met Leu Ala Asp His Arg Leu Lys Leu Glu Asp Tyr Lys Asp Arg Leu 1 5 10 15 Lys Ser Gly Glu His Leu Asn Pro Asp Gln Leu Glu Ala Val Glu Lys 20 25 30 Tyr Glu Glu Val Leu His Asn Leu Glu Phe Ala Lys Glu Leu Gln Lys 35 40 45 Thr Phe Ser Gly Leu Ser Leu Asp Leu Leu Lys Ala Gln Lys Lys Ala 50 55 60 Gln Arg Arg Glu His Met Leu Lys Leu Glu Ala Glu Lys Lys Lys Leu 65 70 75 80 Arg Thr Ile Leu Gln Val Gln Tyr Val Leu Gln Asn Leu Thr Gln Glu 85 90 95 His Val Gln Lys Asp Phe Lys Gly Gly Leu Asn Gly Ala Val Tyr Leu 100 105 110 Pro Ser Lys Glu Leu Asp Tyr Leu Ile Lys Phe Ser Lys Leu Thr Cys 115 120 125 Pro Glu Arg Asn Glu Ser Leu Ser Val Glu Asp Gln Met Glu Gln Ser 130 135 140 Ser Leu Tyr Phe Trp Asp Leu Leu Glu Gly Ser Glu Lys Ala Val Val 145 150 155 160 Gly Thr Thr Tyr Lys His Leu Lys Asp Leu Leu Ser Lys Leu Leu Asn 165 170 175 Ser Gly Tyr Phe Glu Ser Ile Pro Val Pro Lys Asn Ala Lys Glu Lys 180 185 190 Glu Val Pro Leu Glu Glu Glu Met Leu Ile Gln Ser Glu Lys Lys Thr 195 200 205 Gln Leu Ser Lys Thr Glu Ser Val Lys Glu Ser Glu Ser Leu Met Glu 210 215 220 Phe Ala Gln Pro Glu Ile Gln Pro Gln Glu Phe Leu Asn Arg Arg Tyr 225 230 235 240 Met Thr Glu Val Asp Tyr Ser Asn Lys Gln Gly Glu Glu Gln Pro Trp 245 250 255 Glu Ala Asp Tyr Ala Arg Lys Pro Asn Leu Pro Lys Arg Trp Asp Met 260 265 270 Leu Thr Glu Pro Asp Gly Gln Glu Lys Lys Gln Glu Ser Phe Lys Ser 275 280 285 Trp Glu Ala Ser Gly Lys His Gln Glu Val Ser Lys Pro Ala Val Ser 290 295 300 Leu Glu Gln Arg Lys Gln Asp Thr Ser Lys Leu Arg Ser Thr Leu Pro 305 310 315 320 Glu Glu Gln Lys Lys Gln Glu Ile Ser Lys Ser Lys Pro Ser Pro Ser 325 330 335 Gln Trp Lys Gln Asp Thr Pro Lys Ser Lys Ala Gly Tyr Val Gln Glu 340 345 350 Glu Gln Lys Lys Gln Glu Thr Pro Lys Leu Trp Pro Val Gln Leu Gln 355 360 365 Lys Glu Gln Asp Pro Lys Lys Gln Thr Pro Lys Ser Trp Thr Pro Ser 370 375 380 Met Gln Ser Glu Gln Asn Thr Thr Lys Ser Trp Thr Thr Pro Met Cys 385 390 395 400 Glu Glu Gln Asp Ser Lys Gln Pro Glu Thr Pro Lys Ser Trp Glu Asn 405 410 415 Asn Val Glu Ser Gln Lys His Ser Leu Thr Ser Gln Ser Gln Ile Ser 420 425 430 Pro Lys Ser Trp Gly Val Ala Thr Ala Ser Leu Ile Pro Asn Asp Gln 435 440 445 Leu Leu Pro Arg Lys Leu Asn Thr Glu Pro Lys Asp Val Pro Lys Pro 450 455 460 Val His Gln Pro Val Gly Ser Ser Ser Thr Leu Pro Lys Asp Pro Val 465 470 475 480 Leu Arg Lys Glu Lys Leu Gln Asp Leu Met Thr Gln Ile Gln Gly Thr 485 490 495 Cys Asn Phe Met Gln Glu Ser Val Leu Asp Phe Asp Lys Pro Ser Ser 500 505 510 Ala Ile Pro Thr Ser Gln Pro Pro Ser Ala Thr Pro Gly Ser Pro Val 515 520 525 Ala Ser Lys Glu Gln Asn Leu Ser Ser Gln Ser Asp Phe Leu Gln Glu 530 535 540 Pro Leu Gln Ala Thr Ser Ser Pro Val Thr Cys Ser Ser Asn Ala Cys 545 550 555 560 Leu Val Thr Thr Asp Gln Ala Ser Ser Gly Ser Glu Thr Glu Phe Met 565 570 575 Thr Ser Glu Thr Pro Glu Ala Ala Ile Pro Pro Gly Lys Gln Pro Ser 580 585 590 Ser Leu Ala Ser Pro Asn Pro Pro Met Ala Lys Gly Ser Glu Gln Gly 595 600 605 Phe Gln Ser Pro Pro Ala Ser Ser Ser Ser Val Thr Ile Asn Thr Ala 610 615 620 Pro Phe Gln Ala Met Gln Thr Val Phe Asn Val Asn Ala Pro Leu Pro 625 630 635 640 Pro Arg Lys Glu Gln Glu Ile Lys Glu Ser Pro Tyr Ser Pro Gly Tyr 645 650 655 Asn Gln Ser Phe Thr Thr Ala Ser Thr Gln Thr Pro Pro Gln Cys Gln 660 665 670 Leu Pro Ser Ile His Val Glu Gln Thr Val His Ser Gln Glu Thr Ala 675 680 685 Ala Asn Tyr His Pro Asp Gly Thr Ile Gln Val Ser Asn Gly Ser Leu 690 695 700 Ala Phe Tyr Pro Ala Gln Thr Asn Val Phe Pro Arg Pro Thr Gln Pro 705 710 715 720 Phe Val Asn Ser Arg Gly Ser Val Arg Gly Cys Thr Arg Gly Gly Arg 725 730 735 Leu Ile Thr Asn Ser Tyr Arg Ser Pro Gly Gly Tyr Lys Gly Phe Asp 740 745 750 Thr Tyr Arg Gly Leu Pro Ser Ile Ser Asn Gly Asn Tyr Ser Gln Leu 755 760 765 Gln Phe Gln Ala Arg Glu Tyr Ser Gly Ala Pro Tyr Ser Gln Arg Asp 770 775 780 Asn Phe Gln Gln Cys Tyr Lys Arg Gly Gly Thr Ser Gly Gly Pro Arg 785 790 795 800 Ala Asn Ser Arg Ala Asn Cys Phe Ile Met Arg Asn Ser Leu Leu Leu 805 810 815 Ile Lys Gln Gln Gly Gly Val Ile Leu Leu Arg 820 825 43 4342 DNA homo sapiens misc_feature (1)...(4342) n = A,T,C or G 43 ctcgggtgct tggaggtcga gagacggata cgtaagtgcg caagggccac tgattagggc 60 acgggaaggg ctcgctagaa tgagctctta aactggttgg gtgtaagcgg ttttgggcta 120 gtctaaacca aacaactgag aataaacgcg gggttcctgc aggttgagag agtacctgtc 180 tgcaaatgtc cagtagtgat ggattgcctt gtaggcccca gagcaatcgg ggaagttagc 240 attcttgttc aagaagctgc tggttcactt agagctataa aagaatgttg tgagtttgga 300 ttttcttcca aacgttcagg attgaggtta gggctggngg tgagggatca tgtaaagagg 360 tttgagtggc tcaaccttag gtcccggngt ggaaagctta ttcttttggt gtcatcacgt 420 ggccatggga attatttaga atgtgatctg ccctcatgag aagaaaggag ctctgaagcc 480 cgttgcaagt tcttcctccc tatgtggaaa atcgaatttc tggaaacatc ctccgtattg 540 ggagattttg cctatgtaaa ggctatcctt attggctagc ggcactaatt actttaaaag 600 taggatggaa gtacaagtat ctcaagcatc attgggtttc gagctcactt ctgtggaaaa 660 gagtttaagg gagtggtcta gactttccag ggaagttatt gcctggctgt gtccctctag 720 tcctaatttt atacttaact ttcccccacc tccttcagcc tcatctgttt caatggtgca 780 actcttttca tccccttttg gttaccagtc accttcaggc cattcagagg aggaaagaga 840 ggggaatatg aagtcagcca agccccaagt gaaccacagt cagcatgggg aaagccagcg 900 ggccttgagc cccctgcagt ctactctgag ttctgctgca tctccttccc aagcgtatga 960 gacctatatt gaaaatggac tcatatgcct taaacacaaa attagaaaca tcgagaaaaa 1020 gaagctcaaa ctggaggatt ataaggatcg cctgaaaagt ggagagcatc ttaatccaga 1080 ccagttggaa gctgtagaga aatatgaaga agtgctacat aatttggaat ttgccaagga 1140 gcttcaaaaa accttttctg ggttgagcct agatctacta aaagcgcaaa agaaggccca 1200 gagaagggag cacatgctaa aacttgaggc tgagaagaaa aagcttcgaa ctatacttca 1260 agttcagtat gtattgcaga acttgacaca ggagcacgta caaaaagact tcaaaggggg 1320 tttgaatggt gcagtgtatt tgccttcaaa agaacttgac tacctcatta agttttcaaa 1380 actgacctgc cctgaaagaa atgaaagtct gagtgttgaa gaccagatgg agcagtcatc 1440 cttgtacttt tgggaccttt tggaaggtag tgagaaagca gtggtaggaa cgacatacaa 1500 acacttgaag gatctactgt ctaaattgct gaactcaggc tattttgaaa gtatcccagt 1560 tcccaaaaat gccaaggaaa aggaagtacc actggaggaa gaaatgctaa tacaatcaga 1620 gaaaaaaaca caattatcga agactgaatc tgtcaaagag tcagagtctc taatggaatt 1680 tgcccagcca gagatacaac cacaagagtt tcttaacaga cgctatatga cagaagtaga 1740 ttattcaaac aaacaaggcg aagagcaacc ttgggaagca gattatgcta gaaaaccaaa 1800 tctcccaaaa cgttgggata tgcttactga accagatggt caagagaaga aacaggagtc 1860 ctttaagtcc tgggaggctt ctggtaagca ccaggaggta tccaagcctg cagtttcctt 1920 agaacagagg aaacaagaca cctcaaaact caggtctact ctgccggaag agcagaagaa 1980 gcaggagatc tccaaatcca agccatctcc tagccagtgg aagcaagata cacctaaatc 2040 caaagcaggg tatgttcaag aggaacaaaa gaaacaggag acaccaaagc tgtggccagt 2100 tcagctgcag aaagaacaag atccaaagaa gcaaactcca aagtcttgga caccttccat 2160 gcagagcgaa cagaacacca ccaagtcatg gaccactccc atgtgtgaag aacaggattc 2220 aaaacagcca gagactccaa aatcctggga aaacaatgtt gagagtcaaa aacactcttt 2280 aacatcacag tcacagattt ctccaaagtc ctggggagta gctacagcaa gcctcatacc 2340 aaatgaccag ctgctgccca ggaagttgaa cacagaaccc aaagatgtgc ctaagcctgt 2400 gcatcagcct gtaggttctt cctctaccct tccgaaggat ccagtattga ggaaagaaaa 2460 actgcaggat ctgatgactc agattcaagg aacttgtaac tttatgcaag agtctgttct 2520 tgactttgac aaaccttcaa gtgcaattcc aacgtcacaa ccgccttcag ctactccagg 2580 tagccccgta gcatctaaag aacaaaatct gtccagtcaa agtgattttc ttcaagagcc 2640 gttacaggct acttcttctc cagttacttg tagctcaaat gcttgcttgg ttactaccga 2700 tcaggcttct tctggatctg aaacagagtt tatgacctca gagactcctg aggcagcaat 2760 tcccccaggc aagcaaccgt cttcactagc ttctccaaat cctcccatgg caaagggctc 2820 tgaacagggc ttccagtcac ctccagcaag tagtagttca gtaaccatta acacagcacc 2880 ctttcaagcc atgcagacag tatttaacgt taatgcacct ctgcctccac gaaaagaaca 2940 agaaataaaa gaatcccctt attcacctgg ctacaatcaa agttttacca cagcaagtac 3000 acaaacacca ccccagtgcc aactgccatc tatacatgta gaacaaactg tccattctca 3060 agagactgca gcaaattatc atcctgatgg aactattcaa gtaagcaatg gtagccttgc 3120 cttttaccca gcacagacga atgtgtttcc cagacctact cagccatttg tcaatagccg 3180 gggatctgtt agaggatgta ctcgtggtgg gagattaata accaattcct atcggtcccc 3240 tggtggttat aaaggttttg atacttatag aggactccct tcaatttcca atggaaatta 3300 tagccagctg cagttccaag ctagagagta ttctggagca ccttattccc aaagggataa 3360 tttccagcag tgttataagc gaggagggac atctggtggt ccacgagcaa attcgagagc 3420 agggtggagt gattcttctc aggtgagcag cccagaaaga gacaacgaaa cctttaacag 3480 tggtgactct ggacaaggag actcccgtag catgacccct gtggatgtgc cagtgacaaa 3540 tccagcagcc accatactgc cagtacacgt ctaccctctg cctcagcaga tgcgagttgc 3600 cttctcagca gccagaacct ctaatctggc ccctggaact ttagaccaac ctattgtgtt 3660 tgatcttctt ctgaacaact taggagaaac ttttgatctt cagcttggta gatttaattg 3720 cccagtgaat ggcacttacg ttttcatttt tcacatgcta aagctggcag tgaatgtgcc 3780 actgtatgtc aacctcatga agaatgaaga ggtcttggta tcagcctatg ccaatgatgg 3840 tgctccagac catgaaactg ctagcaatca tgcaattctt cagctcttcc agggagacca 3900 gatatggtta cgtctgcaca ggggagcaat ttatggaagt agctggaaat attctacgtt 3960 ttcaggctat cttctttatc aagattgaaa gtcagtacag tattgacaat aaaaggatgg 4020 tgttctaatt agtgggattg aaggaaaagt agtctttgcc ctcatgactg attggtttag 4080 gaaaatgttt ttgttcctag agggaggagg tccttacttt tttgttttcc ttcctgaggt 4140 gaaaaatcaa gctgaatgac aattagcact aatctggcac tttataaatt gtgatgtagc 4200 ctcgctagtc aagctgtgaa tgtatattgt ttgcacttaa tccttaactg tattaacgtt 4260 cagcttacta aactgactgc ctcaagtcca ggcaagttac aatgccttgt tgtgcctcaa 4320 taaaaaagtt acatgcaaaa aa 4342 

What is claimed is:
 1. An isolated nucleic acid molecule comprising at least 24 contiguous bases of nucleotide sequence first disclosed in the NHP polynucleotide described in SEQ ID NO:15.
 2. An isolated nucleic acid molecule comprising a nucleotide sequence that: (a) encodes the amino acid sequence shown in SEQ ID NO:16; and (b) hybridizes under stringent conditions to the nucleotide sequence of SEQ ID NO:15 or the complement thereof.
 3. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes the amino acid sequence shown in SEQ ID NO:16.
 4. An isolated nucleic acid molecule comprising a nucleotide sequence that: (a) encodes the amino acid sequence shown in SEQ ID NO:28; and (b) hybridizes under stringent conditions to the nucleotide sequence of SEQ ID NO:27 or the complement thereof.
 5. An isolated nucleic acid molecule comprising a nucleotide sequence that encodes the amino acid sequence shown in SEQ ID NO:28. 